<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Adjuvant therapy with antidepressants for the management of inflammatory bowel disease - Mikocka‐Walus, A - 2019 | Cochrane Library</title> <meta content="Adjuvant therapy with antidepressants for the management of inflammatory bowel disease - Mikocka‐Walus, A - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012680.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Adjuvant therapy with antidepressants for the management of inflammatory bowel disease - Mikocka‐Walus, A - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012680.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012680.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Adjuvant therapy with antidepressants for the management of inflammatory bowel disease" name="citation_title"/> <meta content="Antonina Mikocka‐Walus" name="citation_author"/> <meta content="Deakin University Geelong" name="citation_author_institution"/> <meta content="antonina.mikockawalus@deakin.edu.au" name="citation_author_email"/> <meta content="Stephanie L Prady" name="citation_author"/> <meta content="University of York" name="citation_author_institution"/> <meta content="Justyna Pollok" name="citation_author"/> <meta content="The University of Adelaide" name="citation_author_institution"/> <meta content="Adrian J Esterman" name="citation_author"/> <meta content="Andrea L Gordon" name="citation_author"/> <meta content="University of South Australia" name="citation_author_institution"/> <meta content="Simon Knowles" name="citation_author"/> <meta content="Swinburne University of Technology" name="citation_author_institution"/> <meta content="Jane M Andrews" name="citation_author"/> <meta content="Royal Adelaide Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD012680.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/04/12" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012680.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012680.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012680.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Antidepressive Agents [*therapeutic use]; Anxiety [drug therapy]; Case-Control Studies; Depression [*drug therapy]; Inflammatory Bowel Diseases [*psychology]; Quality of Life; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012680.pub2&amp;doi=10.1002/14651858.CD012680.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="gpg7sF9V";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012680\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012680\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012680\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012680\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","ms","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012680.pub2",title:"Adjuvant therapy with antidepressants for the management of inflammatory bowel disease",firstPublishedDate:"Apr 12, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gut Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=gpg7sF9V&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012680.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012680.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012680.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012680.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012680.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012680.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012680.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012680.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012680.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012680.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6490 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012680.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/full#CD012680-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/full#CD012680-sec-0088"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/full#CD012680-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/full#CD012680-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/full#CD012680-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/full#CD012680-sec-0022"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/full#CD012680-sec-0045"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/full#CD012680-sec-0082"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/appendices#CD012680-sec-0093"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/table_n/CD012680StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/table_n/CD012680StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Adjuvant therapy with antidepressants for the management of inflammatory bowel disease</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/information#CD012680-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Antonina Mikocka‐Walus</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/information#CD012680-cr-0003">Stephanie L Prady</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/information#CD012680-cr-0004">Justyna Pollok</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/information#CD012680-cr-0005">Adrian J Esterman</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/information#CD012680-cr-0006">Andrea L Gordon</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/information#CD012680-cr-0007">Simon Knowles</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012680.pub2/information#CD012680-cr-0008">Jane M Andrews</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/information/en#CD012680-sec-0099">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 12 April 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012680.pub2">https://doi.org/10.1002/14651858.CD012680.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012680-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012680-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012680-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012680-abs-0008">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012680-abs-0001" lang="en"> <section id="CD012680-sec-0001"> <h3 class="title" id="CD012680-sec-0001">Background</h3> <p>Symptoms of anxiety and depression are common in inflammatory bowel disease (IBD). Antidepressants are taken by approximately 30% of people with IBD. However, there are no current guidelines on treating co‐morbid anxiety and depression in people with IBD with antidepressants, nor are there clear data on the role of antidepressants in managing physical symptoms of IBD. </p> </section> <section id="CD012680-sec-0002"> <h3 class="title" id="CD012680-sec-0002">Objectives</h3> <p>The objectives were to assess the efficacy and safety of antidepressants for treating anxiety and depression in IBD, and to assess the effects of antidepressants on quality of life (QoL) and managing disease activity in IBD. </p> </section> <section id="CD012680-sec-0003"> <h3 class="title" id="CD012680-sec-0003">Search methods</h3> <p>We searched MEDLINE; Embase, CINAHL, PsycINFO, CENTRAL, and the Cochrane IBD Group Specialized Register from inception to 23 August 2018. Reference lists, trials registers, conference proceedings and grey literature were also searched. </p> </section> <section id="CD012680-sec-0004"> <h3 class="title" id="CD012680-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) and observational studies comparing any type of antidepressant to placebo, no treatment or an active therapy for IBD were included. </p> </section> <section id="CD012680-sec-0005"> <h3 class="title" id="CD012680-sec-0005">Data collection and analysis</h3> <p>Two authors independently screened search results, extracted data and assessed bias using the Cochrane risk of bias tool. We used the Newcastle‐Ottawa Scale to assess quality of observational studies. GRADE was used to evaluate the certainty of the evidence supporting the outcomes. Primary outcomes included anxiety and depression. Anxiety was assessed using the Hospital Anxiety and Depression Scale (HADS) or the Hamilton Anxiety Rating Scale (HARS). Depression was assessed using HADS or the Beck Depression Inventory. Secondary outcomes included adverse events (AEs), serious AEs, withdrawal due to AEs, quality of life (QoL), clinical remission, relapse, pain, hospital admissions, surgery, and need for steroid treatment. QoL was assessed using the WHO‐QOL‐BREF questionnaire. We calculated the risk ratio (RR) and corresponding 95% confidence intervals (CI) for dichotomous outcomes. For continuous outcomes, we calculated the mean difference (MD) with 95% CI. A fixed‐effect model was used for analysis. </p> </section> <section id="CD012680-sec-0006"> <h3 class="title" id="CD012680-sec-0006">Main results</h3> <p>We included four studies (188 participants). Two studies were double‐blind RCTs, one was a non‐randomised controlled trial, and one was an observational retrospective case‐matched study. The age of participants ranged from 27 to 37.8 years. In three studies participants had quiescent IBD and in one study participants had active or quiescent IBD. Participants in one study had co‐morbid anxiety or depression. One study used duloxetine (60 mg daily), one study used fluoxetine (20 mg daily), one study used tianeptine (36 mg daily), and one study used various antidepressants in clinical ranges. Three studies had placebo controls and one study had a no treatment control group. One RCT was rated as low risk of bias and the other was rated as high risk of bias (incomplete outcome data). The non‐randomised controlled trial was rated as high risk of bias (random sequence generation, allocation concealment, blinding). The observational study was rated as high methodological quality, but is still considered to be at high risk of bias given its observational design. </p> <p>The effect of antidepressants on anxiety and depression is uncertain. At 12 weeks, the mean anxiety score in antidepressant participants was 6.11 + 3 compared to 8.5 + 3.45 in placebo participants (MD ‐2.39, 95% ‐4.30 to ‐0.48, 44 participants, low certainty evidence). At 12 months, the mean anxiety score in antidepressant participants was 3.8 + 2.5 compared to 4.2 + 4.9 in placebo participants (MD ‐0.40, 95% ‐3.47 to 2.67, 26 participants; low certainty evidence). At 12 weeks, the mean depression score in antidepressant participants was 7.47 + 2.42 compared to 10.5 + 3.57 in placebo participants (MD ‐3.03, 95% CI ‐4.83 to ‐1.23, 44 participants; low certainty evidence). At 12 months, the mean depression score in antidepressant participants was 2.9 + 2.8 compared to 3.1 + 3.4 in placebo participants (MD ‐0.20, 95% ‐2.62 to 2.22, 26 participants; low certainty evidence). </p> <p>The effect of antidepressants on AEs is uncertain. Fifty‐seven per cent (8/14) of antidepressant participants group reported AEs versus 25% (3/12) of placebo participants (RR 2.29, 95% CI 0.78 to 6.73, low certainty evidence). Commonly reported AEs include nausea, headache, dizziness, drowsiness, sexual problems, insomnia, fatigue, low mood/anxiety, dry mouth, muscle spasms and hot flushes. None of the included studies reported any serious AEs. None of the included studies reported on pain. </p> <p>One study (44 participants) reported on QoL at 12 weeks and another study (26 participants) reported on QoL at 12 months. Physical, Psychological, Social and Environmental QoL were improved at 12 weeks compared to placebo (all low certainty evidence). There were no group differences in QoL at 12 months (all low certainty evidence). The effect of antidepressants on maintenance of clinical remission and endoscopic relapse is uncertain. At 12 months, 64% (9/14) of participants in the antidepressant group maintained clinical remission compared to 67% (8/12) of placebo participants (RR 0.96, 95% CI 0.55 to 1.69; low certainty evidence). At 12 months, none (0/30) of participants in the antidepressant group had endoscopic relapse compared to 10% (3/30) of placebo participants (RR 0.14, 95% CI 0.01 to 2.65; very low certainty evidence). </p> </section> <section id="CD012680-sec-0007"> <h3 class="title" id="CD012680-sec-0007">Authors' conclusions</h3> <p>The results for the outcomes assessed in this review are uncertain and no firm conclusions regarding the efficacy and safety of antidepressants in IBD can be drawn. Future studies should employ RCT designs, with a longer follow‐up and develop solutions to address attrition. Inclusion of objective markers of disease activity is strongly recommended as is testing antidepressants from different classes, as at present it is unclear if any antidepressant (or class thereof) has differential efficacy. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012680-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012680-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012680-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012680-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD012680-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012680-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012680-abs-0004">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012680-abs-0003" lang="en"> <h3>Antidepressants for inflammatory bowel disease</h3> <p><b>What is inflammatory bowel disease?</b> </p> <p>Inflammatory bowel disease (IBD) is a chronic, inflammatory disease affecting the gastrointestinal tract (colon or small intestine or both). IBD predominantly comprises Crohn's disease and ulcerative colitis. Symptoms of IBD include diarrhoea, urgency of defecation (including faecal incontinence), abdominal pain, rectal bleeding, fatigue and weight loss. When people experience symptoms of IBD they are considered to have active disease. When symptoms of IBD stop the disease is in remission. IBD is associated with a psycho‐social burden, with rates of depression in people with IBD twice as high as in the general population. Anxiety and depression which accompany IBD may be associated with poor quality of life, worsening IBD activity, higher hospitalisation rates and lower adherence to treatment. Up to 30% of people living with IBD take antidepressants which are prescribed for either mental health or bowel symptoms or both. </p> <p><b>What are antidepressants?</b> </p> <p>Antidepressants are drugs used to treat depression and other mental disorders such as anxiety. No antidepressants are currently approved by regulatory agencies for specifically treating anxiety and depression, to manage physical symptoms or to reduce bowel inflammation in people with IBD. However, some antidepressants have indications for treatment of pain in chronic conditions and have been commonly used to manage functional bowel symptoms in conditions such as irritable bowel syndrome. </p> <p><b>What did the researchers investigate?</b> </p> <p>Previously conducted studies of antidepressant therapy in IBD were reviewed. The data from some of these studies were combined using a method called a meta‐analysis. During the analysis, people who took antidepressants were compared with those who did not take antidepressants with regard to rates of anxiety and depression and also other measures such as quality of life, side effects and IBD disease activity. </p> <p><b>What did the researchers find?</b> </p> <p>The researchers searched the medical literature up to 23 August 2018. Four published studies, including a total of 188 people, examined antidepressant therapy in people with IBD. The age of participants ranged from 27 to 37.8 years. In three studies participants had IBD in remission and in one study participants had either active IBD or IBD in remission. Participants in one study had co‐existing anxiety or depression. One study used duloxetine (60 mg daily), one study used fluoxetine (20 mg daily), one study used tianeptine (36 mg daily), and one study used various antidepressants. Three studies had a placebo (e.g. sugar pill) control group and one study had a no treatment control group. </p> <p>The analysis showed that the symptoms of anxiety and depression were improved in those who took antidepressants compared to placebo. Participants who received antidepressants experienced more side effects than those who received placebo. Side effects reported by those taking antidepressants included: nausea, headache, dizziness, drowsiness, sexual problems, insomnia, fatigue, low mood/anxiety, dry mouth, poor sleep, restless legs and hot flushes. Some aspects of quality of life were improved as was IBD activity in the antidepressant group. The overall quality of the studies included in this review was poor because the studies included small numbers of participants, and involved IBD populations which differed from each other on key characteristics. In addition, different types of antidepressants were assessed so the evidence for any one antidepressant was uncertain. Therefore, future studies are needed to confirm these observations. </p> <p><b>Conclusion</b> </p> <p>The results for the outcomes assessed in this review are uncertain and no firm conclusions regarding the benefits and harms of antidepressants in IBD can be drawn. More studies are needed to allow for firm conclusions regarding the benefits and harms of the use of antidepressants in people with IBD. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012680-sec-0088" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012680-sec-0088">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012680-sec-0142">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012680-sec-0088"></div> <h3 class="title" id="CD012680-sec-0089">Implications for practice</h3> <section id="CD012680-sec-0089"> <p>The results for the outcomes assessed in this review are uncertain and no firm conclusions regarding the efficacy and safety of antidepressants in IBD can be drawn. </p> </section> <h3 class="title" id="CD012680-sec-0090">Implications for research</h3> <section id="CD012680-sec-0090"> <p>Adequately‐powered high quality trials examining the role of antidepressants as an adjuvant therapy to manage psychological and physical symptoms of IBD are warranted. Future studies should employ blinded RCT designs which are the gold standard for drug trials. These studies should include follow‐up beyond post‐treatment, while at the same time developing solutions to address attrition, which was a concern in one study included in this review (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>). Attrition could result from adverse events, however, this was not confirmed by the present review, with no group differences in study drop out due to adverse events. The inclusion of objective markers of disease activity is strongly recommended. Testing antidepressants from different groups is also warranted, as at present it is unclear if one group of antidepressants is superior to the other groups. The present review shows that the positive results occur across different classes of antidepressant and thus there is the potential for flexibility and tailoring of treatment. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012680-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012680-sec-0015"></div> <div class="table" id="CD012680-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antidepressants compared to placebo for inflammatory bowel disease</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Antidepressants compared to placebo for inflammatory bowel disease</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with active and inactive inflammatory bowel disease<br/> <b>Setting:</b> Outpatient<br/> <b>Intervention:</b> Antidepressants<br/> <b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Antidepressants</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anxiety at 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean anxiety was 8.5 (SD = 3.45)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean anxiety was 6.11 (SD = 3)</p> <p>MD 2.39 lower<br/> (‐4.3 lower to ‐0.48 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anxiety was assessed using the HADS</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anxiety at 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean anxiety was 4.2 (SD = 4.9)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean anxiety was 3.8 (SD = 2.5)</p> <p>MD ‐0.40 lower<br/> (‐3.47 lower to 2.67 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anxiety was assessed using the HADS</p> <p>A second non‐randomised study using the HARS reported a mean score of 12.65 + 3.76 in the antidepressant group (n = 30) compared to 17.85 + 3.33 in the placebo group (n = 30) (MD ‐5.20, 95% CI ‐7 to ‐3.40; very low certainty evidence) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depression at 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean depression was 10.5 (SD = 3.57)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean depression was 7.47 (SD = 2.42)</p> <p>MD ‐3.03 lower<br/> (‐4.83 lower to ‐1.23 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depression was assessed using the HADS</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depression at 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean depression was 3.1 (SD = 3.4)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean depression was 2.9 (SD = 2.8)</p> <p>MD ‐0.20 lower<br/> (‐2.62 lower to 2.22 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depression was assessed using the HADS</p> <p>A second non‐randomised study using the Beck Depression Inventory reported a mean score of 9.6 + 2.76 in the antidepressant group (n = 30) compared to 16.35 + 5.41 in the placebo group (n = 30) (MD ‐6.75, 95% CI ‐8.92 to ‐4.58; very low certainty evidence) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events at 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>250 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>573 per 1,000<br/> (195 to 1,000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.29<br/> (0.78 to 6.73) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Commonly reported adverse events include nausea, headache, dizziness, drowsiness, sexual problems, insomnia, fatigue, low mood/anxiety, dry mouth muscle spasms and hot flushes </p> <p>None of the included studies reported any serious adverse events</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1, 2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life was assessed using the WHO‐QOL‐BREF</p> <p>We were unable to pool data as the outcome was reported at 12 weeks in 1 trial (44 participants) and 12 months in 1 trial (26 participants). Physical, Psychological, Social and Environmental QoL were improved only at 12 weeks with no group difference at 12 months </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maintenance of remission at 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>667 per 1,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>640 per 1,000<br/> (367 to 1,000) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.96<br/> (0.55 to 1.69) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26<br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maintenance of remission was measured by the CDAI (&lt; 150) and fecal calprotectin levels</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endoscopic relapse at 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1,000<br/> (0 to 0) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.14<br/> (0.01 to 2.65) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60<br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐randomised study. We were unable to calculate absolute effects. Endoscopic relapse occurred in 0% (0/30) of participants in the antidepressants group compared to 10% (3/30) in the placebo group </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>CMD</b> : Common mental disorders; <b>MD</b> : Mean Difference; <b>HADS:</b> Hospital Anxiety and Depression Scale; <b>HARS:</b> Hamilton Anxiety Rating Scale; <b>RR:</b> Risk Ratio; <b>WHO‐QOL‐BREF</b>: World Health Organization Quality of Life abbreviated questionnaire </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to serious imprecision (44 participants) </p> <p><sup>2</sup> Downgraded one level due to high risk of bias (incomplete outcome data) </p> <p><sup>3</sup> Downgraded two levels due very serious imprecision (26 participants) </p> <p><sup>4</sup> Downgraded two levels due very serious imprecision (11 events) </p> <p><sup>5</sup> Downgraded two levels due very serious imprecision (17 events). </p> <p><sup>6</sup> Downgraded one level due to very serious imprecision (3 events) and a large CI around the point estimate </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012680-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012680-sec-0016">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012680-sec-0107">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD012680-sec-0016"></div> <section id="CD012680-sec-0017"> <h3 class="title" id="CD012680-sec-0017">Description of the condition</h3> <p>Inflammatory bowel disease (IBD) is a chronic, inflammatory disease affecting the gastrointestinal tract. The aetiology of IBD is thought to involve an inappropriate immune response to intestinal microbiota, triggered by environmental factors, in genetically susceptible people. The typical symptoms of IBD include diarrhoea, urgency of defecation, abdominal pain and cramping, fatigue, and weight loss. IBD affects 2.2 million people in Europe (<a href="./references#CD012680-bbs2-0046" title="LoftusEV . Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology2004;126(6):1504‐17. ">Loftus 2004</a>), 1.4 million people in the USA (<a href="./references#CD012680-bbs2-0025" title="Crohn's and Colitis Foundation of America. About the Epidemiology of IBD. www.ccfa.org/resources/epidemiology.html (accessed 13 December 2016). ">CCFA 2012</a>), 233,000 people in Canada (<a href="./references#CD012680-bbs2-0061" title="RocchiA , BenchimolEI , BernsteinCN , BittonA , FeaganB , PanaccioneR , et al. Inflammatory bowel disease: a Canadian burden of illness review. Canadian Journal of Gastroenterology2012;26(11):811‐7. ">Rocchi 2012</a>), and over 75,000 people in Australia (<a href="./references#CD012680-bbs2-0024" title="Crohn's , ColitisAustralia . About Crohn's and Colitis. www.crohnsandcolitis.com.au/about‐crohns‐colitis (accessed 13 December 2016). ">CCA 2015</a>). </p> <p>IBD is associated with a psychosocial burden. People with IBD have a higher life‐time prevalence of depression compared to the general community, with estimated rates of 27% in persons with IBD compared to 12% in the general population (<a href="./references#CD012680-bbs2-0070" title="WalkerJR , EdigerJP , GraffLA , GreenfeldJM , ClaraI , LixL , et al. The Manitoba IBD cohort study: a population‐based study of the prevalence of lifetime and 12‐month anxiety and mood disorders. American Journal of Gastroenterology2008;103(8):1989‐97. ">Walker 2008</a>). During IBD remission, over 20% of people report symptoms of anxiety or depression but this number rises to 60% when IBD is active (<a href="./references#CD012680-bbs2-0054" title="Mikocka‐WalusA , KnowlesSR , KeeferL , GraffL . Controversies revisited: A systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. Inflammatory Bowel Diseases2016;22(3):752‐62. ">Mikocka‐Walus 2016a</a>). Psychological stress has been found to predict symptomatic disease course (<a href="./references#CD012680-bbs2-0022" title="BernsteinCN , SinghS , GraffLA , WalkerJR , MillerN , CheangM . A prospective population‐based study of triggers of symptomatic flares in IBD. American Journal of Gastroenterology2011;105(9):1994‐2002. ">Bernstein 2011</a>), and is also linked to increased inflammation (<a href="./references#CD012680-bbs2-0049" title="MaunderRG , LevensteinS . The role of stress in the development and clinical course of inflammatory bowel disease: epidemiological evidence. Current Molecular Medicine2008;8(4):247‐52. ">Maunder 2008</a>). Associations between symptoms of depression and clinical recurrence over time (<a href="./references#CD012680-bbs2-0055" title="Mikocka‐WalusA , PittetV , RosselJB , vonKänelR , Swiss IBD Cohort Study Group. Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease. Clinical Gastroenterology and Hepatology2016;14(6):829‐35. ">Mikocka‐Walus 2016d</a>), higher hospitalisation rates (<a href="./references#CD012680-bbs2-0067" title="vanLangenbergDR , LangeK , HetzelDJ , HoltmannGJ , AndrewsJM . Adverse clinical phenotype in inflammatory bowel disease: a cross sectional study identifying factors potentially amenable to change. Journal of Gastroenterology and Hepatology2010;25(7):1250‐8. ">Van Langenberg 2010</a>), and lower adherence to treatment (<a href="./references#CD012680-bbs2-0057" title="NigroG , AngeliniG , GrossoSB , CaulaG , Sategna‐GuidettiC . Psychiatric predictors of noncompliance in inflammatory bowel disease: psychiatry and compliance. Journal of Clinical Gastroenterology2001;32(1):66‐8. ">Nigro 2001</a>), have also been suggested. </p> <p>Despite the high prevalence of mental co‐morbidities with IBD and the effect on disease course, mental disorders are not routinely treated in this population. In fact, fewer than 40% of those with IBD reporting mental symptoms receive psychotherapy (<a href="./references#CD012680-bbs2-0021" title="Bennebroek EvertszF , BocktingCL , StokkersPC , HinnenC , SandermanR , SprangersMA . The effectiveness of cognitive behavioral therapy on the quality of life of patients with inflammatory bowel disease: multi‐center design and study protocol (KL!C‐ study). BMC Psychiatry2012;12:227. ">Bennebroek Evertsz 2012</a>). Poor access to psychologists may contribute to this finding. In the UK, for example, only a fraction of IBD services (12%) have access to clinical psychology (<a href="./references#CD012680-bbs2-0059" title="Royal College of Physicians. National audit of inflammatory bowel disease (IBD) service provision. www.rcplondon.ac.uk/projects/outputs/ibd‐audit‐and‐transparency‐data (accessed 13 December 2016). ">RCP 2014</a>). However, psychotherapy is not a universal treatment for mental and physical symptoms associated with IBD (<a href="./references#CD012680-bbs2-0066" title="TimmerA , PreissJC , MotschallE , RuckerG , JantschekG , MoserG . Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database of Systematic Reviews2011, Issue 2. [DOI: 10.1002/14651858.CD006913.pub2] ">Timmer 2011</a>). While the most recent meta‐analysis demonstrated that psychological therapies, and cognitive behavioural therapy in particular, might have small short‐term beneficial effects on depression scores and quality of life (QoL) in IBD (<a href="./references#CD012680-bbs2-0038" title="GracieDJ , IrvineAJ , SoodR , Mikocka‐WalusA , HamlinPJ , FordAC . Effect of psychological therapy on disease activity, psychological comorbidity, and quality of life in inflammatory bowel disease: a systematic review and meta‐analysis. Lancet Gastroenterology and Hepatology2017;2(3):189‐199. ">Gracie 2017</a>), there is no evidence that psychotherapies are effective for IBD activity. The limitations of the current studies on psychotherapy in IBD are discussed elsewhere (<a href="./references#CD012680-bbs2-0044" title="KnowlesSR , MonshatK , CastleDJ . The efficacy and methodological challenges of psychotherapy for adults with inflammatory bowel disease: a review. Inflammatory Bowel Diseases2013;19(12):2704‐15. ">Knowles 2013</a>). </p> <p>Depending on the population, 10% to 30% of IBD patients take antidepressants (<a href="./references#CD012680-bbs2-0034" title="Fuller‐ThomsonE , SulmanJ . Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflammatory Bowel Diseases2006;12(8):697‐707. ">Fuller‐Thomson 2006</a>; <a href="./references#CD012680-bbs2-0041" title="HaapamakiJ , TanskanenA , RoineRP , BlomM , TurunenU , MantylaJ , et al. Medication use among inflammatory bowel disease patients: excessive consumption of antidepressants and analgesics. Scandinavian Journal of Gastroenterology2013;48(1):42‐50. ">Haapamaki 2013</a>; <a href="./references#CD012680-bbs2-0053" title="Mikocka‐WalusAA , GordonAL , StewartBJ , AndrewsJM . The role of antidepressants in the management of inflammatory bowel disease (IBD): a short report on a clinical case‐note audit. Journal of Psychosomatic Research2012;72(2):165‐7. ">Mikocka‐Walus 2012</a>). However, studies have shown that those IBD patients who receive antidepressants do not necessarily suffer from depression but often are treated for pain, insomnia or functional bowel symptoms which overlap with IBD (<a href="./references#CD012680-bbs2-0051" title="Mikocka‐WalusAA , TurnbullDA , MouldingNT , WilsonIG , AndrewsJM , HoltmannGJ . &quot;It doesn't do any harm, but patients feel better&quot;: a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease. BMC Gastroenterology2007;7:38. ">Mikocka‐Walus 2007</a>; <a href="./references#CD012680-bbs2-0053" title="Mikocka‐WalusAA , GordonAL , StewartBJ , AndrewsJM . The role of antidepressants in the management of inflammatory bowel disease (IBD): a short report on a clinical case‐note audit. Journal of Psychosomatic Research2012;72(2):165‐7. ">Mikocka‐Walus 2012</a>). This resembles treatment for functional gut disorders such as irritable bowel syndrome, where there is good evidence of antidepressants’ efficacy for physical symptoms (<a href="./references#CD012680-bbs2-0032" title="FordAC , TalleyNJ , SchoenfeldPS , QuigleyEM , MoayyediP . Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta‐analysis. Gut2009;58(3):367‐78. ">Ford 2009</a>; <a href="./references#CD012680-bbs2-0033" title="FordAC , QuigleyEM , LacyBE , LemboAJ , SaitoYA , SchillerLR , et al. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta‐analysis. American Journal of Gastroenterology2014;109(9):1350‐65. ">Ford 2014</a>). However, while antidepressants are used in IBD, the efficacy of this intervention in this population has not been established to date. </p> </section> <section id="CD012680-sec-0018"> <h3 class="title" id="CD012680-sec-0018">Description of the intervention</h3> <p>Antidepressants are drugs used to treat depression and other mental disorders such as anxiety. While lithium was known in the 19<sup>th</sup> century, it wasn't introduced to common psychiatry practice until the 1950s (<a href="./references#CD012680-bbs2-0063" title="ShorterE . The history of lithium therapy. Bipolar Disorders2009;11(Suppl 2):4‐9. ">Shorter 2009</a>). Other antidepressants ‐ monoamine oxidase inhibitors and tricyclics were also introduced in the 1950s while tetracyclics were introduced in the 1970s. Presently, the most commonly used antidepressants are selective serotonin reuptake inhibitors (SSRIs) which were introduced in the 1980s. Serotonin‐norepinephrine reuptake inhibitors (SNRIs) became available in the 1990s. Other less commonly known groups of antidepressants include: heterocyclics, norepinephrine reuptake inhibitors (NARIs), norepinephrine–dopamine reuptake inhibitors (NDRIs), noradrenergic and specific serotonergic antidepressants (NaASSAs), and serotonin antagonist and reuptake inhibitors (SARIs). </p> <p>Dosage regimens differ between the different classes and individual antidepressants, and depend on the severity of symptoms. Antidepressants are usually taken daily (either morning or night) and the treatment ranges from several months to several years or even lifetime use. The efficacy of older antidepressants (e.g. tricyclics) and newer, second‐generation antidepressants (e.g. SSRI) is similar (<a href="./references#CD012680-bbs2-0073" title="WilliamsJW , MulrowCD , ChiquetteE , NoelPH , AguilarC , CornellJ . A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Annals of Internal Medicine2000;132(9):743‐56. ">Williams 2000</a>). However, the use of first generation antidepressants is associated with more serious adverse events, with increased lethality with overdose (<a href="./references#CD012680-bbs2-0035" title="GartlehnerG , HansenRA , ThiedaP , DeVeaugh‐GeissAM , GaynesBN , KrebsEE , et al. Comparative effectiveness of second‐generation antidepressants in the pharmacologic treatment of adult depression. Rockville, MD: Agency for Healthcare Research and Quality, 2007. ">Gartlehner 2007</a>; <a href="./references#CD012680-bbs2-0036" title="GartlehnerG , HansenRA , MorganLC , ThalerK , LuxLJ , VanNoordM , et al. Second‐generation antidepressants in the pharmacologic treatment of adult depression: An update of the 2007 comparative effectiveness review. Rockville, MD: Agency for Healthcare Research and Quality, 2011. ">Gartlehner 2011</a>), and thus these agents are no longer first line pharmacotherapy treatment for depression or anxiety. Among the new generation antidepressants, escitalopram and sertraline are considered to be superior to other commonly used antidepressants in terms of efficacy and acceptability (<a href="./references#CD012680-bbs2-0026" title="CiprianiA , FurukawaTA , SalantiG , GeddesJR , HigginsJP , ChurchillR , et al. Comparative efficacy and acceptability of 12 new‐generation antidepressants: a multiple‐treatments meta‐analysis. Lancet2009;28(373):746‐58. ">Cipriani 2009</a>). </p> <p>No antidepressants are currently approved by regulatory agencies for specifically treating anxiety and depression comorbid with IBD, to manage physical symptoms of IBD or to reduce bowel inflammation. However, some antidepressants have indications for treatment of pain in chronic conditions. For example, duloxetine has an indication for diabetic peripheral neuropathy (<a href="./references#CD012680-bbs2-0017" title="Australian Medicines Handbook PtyLtd . Duloxetine. Australian Medicines Handbook. Adelaide: Australian Medicines Handbook Pty Ltd, 2012. ">AMH 2012</a>). </p> </section> <section id="CD012680-sec-0019"> <h3 class="title" id="CD012680-sec-0019">How the intervention might work</h3> <p>Antidepressants are thought to work through compensating for transmitter deficits in the brain, which are considered to be the underlying cause of depression (<a href="./references#CD012680-bbs2-0060" title="RitterJM , FlowerR , HendersonG , RangHP . Rang &amp; Dale's Pharmacology. 8th Edition. London: Churchill Livingstone, 2015. ">Ritter 2015</a>). Antidepressants can either inhibit the reuptake of neurotransmitters from the synaptic cleft or inhibit the metabolism of neurotransmitters. Thus, for example, tricyclics inhibit the uptake of noradrenaline or serotonin or both. SSRIs inhibit serotonin uptake, while SNRIs inhibit both noradrenaline and serotonin uptake, and monoamine oxidase inhibitors inhibit the metabolism of mono‐amine neurotransmitters such as serotonin. However, it is also hypothesized that antidepressants may help treat depression due to immunoregulatory effects (<a href="./references#CD012680-bbs2-0048" title="MaesM . The immunoregulatory effects of antidepressants. Human Psychopharmacology2001;16(1):95‐103. ">Maes 2001</a>). A significant drop in serum C‐reactive protein concentrations (independent of depressive symptoms being resolved) has been observed following four weeks of treatment with SSRIs in people with a major depressive disorder (<a href="./references#CD012680-bbs2-0058" title="O'BrienSM , ScottLV , DinanTG . Antidepressant therapy and C‐reactive protein levels. British Journal of Psychiatry2006;188:449‐52. ">O'Brien 2006</a>). Even in healthy volunteers, antidepressants have been shown to improve immunoregulatory activity (<a href="./references#CD012680-bbs2-0065" title="Szuster‐CiesielskaA , Tustanowska‐StachuraA , SlotwinskaM , Marmurowska‐MichalowskaH , Kandefer‐SzerszenM . In vitro immunoregulatory effects of antidepressants in healthy volunteers. Polish Journal of Pharmacology2003;55(3):353‐62. ">Szuster‐Ciesielska 2003</a>); and in sufferers of chronic inflammatory conditions such as asthma, antidepressants are reported to reduce the need for steroids (<a href="./references#CD012680-bbs2-0023" title="BrownES , VigilL , KhanDA , LigginJD , CarmodyTJ , RushAJ . A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study. Biological Psychiatry2005;58(11):865‐70. ">Brown 2005</a>), and improve overall immune function (<a href="./references#CD012680-bbs2-0045" title="KrommydasG , GourgoulianisKI , KaramitsosK , KrapisK , KotrotsiouE , MolyvdasPA . Therapeutic value of antidepressants in asthma. Medical Hypotheses2005;64(5):938‐40. ">Krommydas 2005</a>). </p> <p>Given the immunoregulatory effect of antidepressants, it is possible that when given to patients with inflammatory conditions such as IBD, antidepressants may exert an effect on inflammation outside the brain and thus improve not only mood but also bowel symptoms, by extending or inducing remission. Animal studies examining models of colitis can serve as a proof of concept (<a href="./references#CD012680-bbs2-0052" title="Mikocka‐WalusA , ClarkeD , GibsonP . Can antidepressants influence the course of inflammatory bowel disease (IBD)? The current state of research. European Gastroenterology and Hepatology Review2009;5(1):48‐53. ">Mikocka‐Walus 2009</a>). For example, mice receiving desipramine (a tricyclic antidepressant) have significantly reduced microscopic damage (P &lt; 0.05) and attenuation of colonic myeloperoxidase activity (P &lt; 0.05) when compared to placebo (<a href="./references#CD012680-bbs2-0068" title="VargheseAK , VerduEF , BercikP , KhanWI , BlennerhassettPA , SzechtmanH , et al. Antidepressants attenuate increased susceptibility to colitis in a murine model of depression. Gastroenterology2006;130(6):1743‐53. ">Varghese 2006</a>). Furthermore, serum Il‐1β concentrations were significantly lower in rats receiving 10 mg fluoxetine (an SSRI), 20 mg fluoxetine, 20 mg desipramine or 10 mg desipramine compared to controls (all P &lt; 0.001) (<a href="./references#CD012680-bbs2-0039" title="GuemeiAA , ElDinNM , BarakaAM , ElSaid DarwishI . Do desipramine [10,11‐dihydro‐5‐[3‐(methylamino) propyl]‐5H‐dibenz[b,f]azepine monohydrochloride] and fluoxetine [N‐methyl‐3‐phenyl‐3‐[4‐(trifluoromethyl)phenoxy]‐propan‐1‐amine] ameliorate the extent of colonic damage induced by acetic acid in rats?. Journal of Pharmacology and Experimental Therapeutics2008;327(3):846‐50. ">Guemei 2008</a>). Similarly, reductions in serum tumour necrosis factor‐alpha were observed in rats receiving either desipramine or fluoxetine (10 or 20 mg) compared to controls (all P &lt; 0.001). Thus, antidepressants can induce an anti‐inflammatory response which is not related to antidepressive effects. </p> <p>Further, treatments which improve inflammation in IBD, such as biologics, are known to also improve QoL (<a href="./references#CD012680-bbs2-0031" title="FeaganBG , ReinischW , RutgeertsP , SandbornWJ , YanS , EisenbergD , et al. The effects of infliximab therapy on health‐related quality of life in ulcerative colitis patients. American Journal of Gastroenterology2007;102(4):794‐802. ">Feagan 2007</a>). Thus, it is hypothesised that antidepressants can reduce symptoms of anxiety and depression and improve QoL in IBD. It is further hypothesised that, similarly to what occurs in animal models where antidepressants have been shown to have anti‐inflammatory properties, antidepressants may induce remission of IBD and reduce the number of flares in humans. </p> </section> <section id="CD012680-sec-0020"> <h3 class="title" id="CD012680-sec-0020">Why it is important to do this review</h3> <p>There is a growing interest in mental health and antidepressant use in chronic illness, to manage comorbid depression as well as physical symptoms, with recent Cochrane systematic reviews conducted on diabetes (<a href="./references#CD012680-bbs2-0019" title="BaumeisterH , HutterN , BengelJ . Psychological and pharmacological interventions for depression in patients with diabetes mellitus: an abridged Cochrane review. Diabetic Medicine2014;31(7):773‐86. ">Baumeister 2014</a>), coronary artery disease (CAD) (<a href="./references#CD012680-bbs2-0018" title="BaumeisterH , HutterN , BengelJ . Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD008012.pub3] ">Baumeister 2011</a>), and functional gut disorders (<a href="./references#CD012680-bbs2-0062" title="RuepertL , QuarteroAO , deWitNJ , van derHeijdenGJ , RubinG , MurisJW . Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews2011, Issue 8. [DOI: 10.1002/14651858.CD003460.pub3] ">Ruepert 2011</a>). These reviews have shown improved glycaemic control after the use of SSRIs versus placebo in patients with diabetes (<a href="./references#CD012680-bbs2-0019" title="BaumeisterH , HutterN , BengelJ . Psychological and pharmacological interventions for depression in patients with diabetes mellitus: an abridged Cochrane review. Diabetic Medicine2014;31(7):773‐86. ">Baumeister 2014</a>); improvements in depression, reduction in hospitalisations and emergency room visits (though no beneficial effects on mortality, cardiac events or QoL) after SSRI use compared to placebo in CAD (<a href="./references#CD012680-bbs2-0018" title="BaumeisterH , HutterN , BengelJ . Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD008012.pub3] ">Baumeister 2011</a>); and improvements in abdominal pain and symptoms (after tricyclics as compared to placebo) and in global assessment (after SSRIs as compared to placebo) in irritable bowel syndrome (<a href="./references#CD012680-bbs2-0062" title="RuepertL , QuarteroAO , deWitNJ , van derHeijdenGJ , RubinG , MurisJW . Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews2011, Issue 8. [DOI: 10.1002/14651858.CD003460.pub3] ">Ruepert 2011</a>). However, there is currently no Cochrane systematic review exploring the role of antidepressants in IBD. </p> <p>The first systematic review on the use of antidepressants in IBD was conducted in 2005 and identified 12 uncontrolled studies (<a href="./references#CD012680-bbs2-0050" title="Mikocka‐WalusAA , TurnbullDA , MouldingNT , WilsonIG , AndrewsJM , HoltmannGJ . Antidepressants and inflammatory bowel disease: a systematic review. Clinical Practice and Epidemiology in Mental Health2006;2:24. ">Mikocka‐Walus 2006</a>). While the review observed a beneficial effect of antidepressants on mental and physical status of IBD patients, the available research was of low quality, making it impossible to provide definitive conclusions on the efficacy of antidepressants for improving outcomes in patients with IBD. A more recent systematic review (<a href="./references#CD012680-bbs2-0047" title="MacerB , PradyS , Mikocka‐WalusA . Antidepressants in inflammatory bowel disease: A systematic review. Inflammatory Bowel Diseases2017;23(4):534‐50. ">Macer 2017</a>), included 15 studies including 1 randomised controlled trial, 2 cohort studies, 1 case‐control study, 1 cross‐sectional survey, 1 qualitative study, 2 audits, 1 case series, and 6 case reports. Twelve studies suggested that antidepressants have a positive impact on IBD course. Nine studies reported on anxiety and depression as outcomes. Eight of these studies reported beneficial effects of antidepressants. Most of the studies were deemed to be at low risk of bias, apart from the case reports, which were at high risk of bias. While this review confirmed the beneficial effect of antidepressants on IBD course, it concluded that it was not possible to determine efficacy of antidepressants for certain due to the lack of randomised controlled trials (RCTs). Since the publication of the latest review another trial of antidepressant use in IBD has been published (<a href="./references#CD012680-bbs2-0056" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2017;11(4):509‐14. ">Mikocka‐Walus 2017</a>). It is now time to review current evidence on the effectiveness and safety of antidepressants for mood and disease activity in IBD patients. It is also critical to conduct the first meta‐analysis of the effects of antidepressants in IBD management. </p> <p>Given the widespread use of antidepressants in IBD (<a href="./references#CD012680-bbs2-0034" title="Fuller‐ThomsonE , SulmanJ . Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflammatory Bowel Diseases2006;12(8):697‐707. ">Fuller‐Thomson 2006</a>; <a href="./references#CD012680-bbs2-0041" title="HaapamakiJ , TanskanenA , RoineRP , BlomM , TurunenU , MantylaJ , et al. Medication use among inflammatory bowel disease patients: excessive consumption of antidepressants and analgesics. Scandinavian Journal of Gastroenterology2013;48(1):42‐50. ">Haapamaki 2013</a>; <a href="./references#CD012680-bbs2-0053" title="Mikocka‐WalusAA , GordonAL , StewartBJ , AndrewsJM . The role of antidepressants in the management of inflammatory bowel disease (IBD): a short report on a clinical case‐note audit. Journal of Psychosomatic Research2012;72(2):165‐7. ">Mikocka‐Walus 2012</a>), and the potential for not only addressing poor mental health but also immunoregulatory activity (<a href="./references#CD012680-bbs2-0045" title="KrommydasG , GourgoulianisKI , KaramitsosK , KrapisK , KotrotsiouE , MolyvdasPA . Therapeutic value of antidepressants in asthma. Medical Hypotheses2005;64(5):938‐40. ">Krommydas 2005</a>), it is important to assess the efficacy and safety of antidepressants in IBD. This review explores the adjuvant role of antidepressants in IBD. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012680-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012680-sec-0021">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012680-sec-0112">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012680-sec-0021"></div> <p>Primary objectives</p> <p> <ul id="CD012680-list-0001"> <li> <p>To assess the efficacy and safety of antidepressants for treating anxiety and depression in IBD. </p> </li> </ul> </p> <p>Secondary objectives</p> <p> <ul id="CD012680-list-0002"> <li> <p>To assess the efficacy and safety of antidepressants for improving QoL in IBD.</p> </li> <li> <p>To assess the efficacy and safety of antidepressants for managing IBD disease activity.</p> </li> </ul> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012680-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012680-sec-0022">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012680-sec-0113">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012680-sec-0022"></div> <section id="CD012680-sec-0023"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012680-sec-0024"> <h4 class="title">Types of studies</h4> <p>All published and unpublished quantitative studies including: RCTs, and non‐randomised controlled studies, prospective and retrospective studies including cohort, case control, cross‐sectional and audit studies, were eligible for inclusion. Studies without a comparison group were excluded. </p> </section> <section id="CD012680-sec-0025"> <h4 class="title">Types of participants</h4> <p>Humans, clinically diagnosed with IBD of any type (i.e. Crohn's disease, ulcerative colitis or indeterminate colitis) – according to standard practice (i.e. a combination of clinical, radiologic, endoscopic and histologic grounds), were considered for inclusion. </p> </section> <section id="CD012680-sec-0026"> <h4 class="title">Types of interventions</h4> <p>All types of antidepressants (in any dose) were included:</p> <p> <ul id="CD012680-list-0003"> <li> <p>SSRIs (citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline);</p> </li> <li> <p>Tricyclics (amitriptyline, clomipramine, desipramine, dothiepin, doxepin, imipramine, lofepramine, nortriptyline, protriptyline, trimipramine); </p> </li> <li> <p>Heterocyclics (mianserin);</p> </li> <li> <p>MAO inhibitors (isocarboxazid, phenelzine, tranylcypromine, brofaromine, moclobemide, tyrima); </p> </li> <li> <p>NARIs (reboxetine);</p> </li> <li> <p>NDRIs (amineptine, buproprion);</p> </li> <li> <p>SNRIs (duloxetine, milnacipran, venlafaxine);</p> </li> <li> <p>NASSAs (mirtazapine);</p> </li> <li> <p>SARIs (trazodone); and</p> </li> <li> <p>Other unclassified antidepressants (agomelatine, vilazodone).</p> </li> </ul> </p> <p>Any comparator including any of the following was considered for inclusion:</p> <p> <ul id="CD012680-list-0004"> <li> <p>No intervention;</p> </li> <li> <p>Placebo;</p> </li> <li> <p>Standard care/treatment as usual;</p> </li> <li> <p>Surgery;</p> </li> <li> <p>Alternative interventions used to treat depression and anxiety, e.g. anxiolytics, psychotherapy; </p> </li> <li> <p>Another antidepressant; and</p> </li> <li> <p>Any other active comparators.</p> </li> </ul> </p> </section> <section id="CD012680-sec-0027"> <h4 class="title">Types of outcome measures</h4> <section id="CD012680-sec-0028"> <h5 class="title">Primary outcomes</h5> <p><b>Efficacy</b> </p> <p> <ul id="CD012680-list-0005"> <li> <p>Anxiety and depression as measured by any well‐established anxiety or depression scale</p> </li> </ul> </p> </section> <section id="CD012680-sec-0029"> <h5 class="title">Secondary outcomes</h5> <p><b>Safety</b> </p> <p> <ul id="CD012680-list-0006"> <li> <p>Adverse events;</p> </li> <li> <p>Serious adverse events;</p> </li> <li> <p>Study withdrawal due to adverse events.</p> </li> </ul> </p> <p><b>Efficacy</b> </p> <p> <ul id="CD012680-list-0007"> <li> <p>QoL as measured by any well‐established QoL scale;</p> </li> <li> <p>IBD clinical remission or relapse;</p> </li> <li> <p>Pain severity as established using any well‐established pain scale; and</p> </li> <li> <p>Hospital admissions, surgery, need for steroid treatment.</p> </li> </ul> </p> </section> </section> </section> <section id="CD012680-sec-0030"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012680-sec-0031"> <h4 class="title">Electronic searches</h4> <p>The following sources were searched from inception to 23rd August 2018 and without language restrictions: </p> <p> <ul id="CD012680-list-0008"> <li> <p>MEDLINE via PubMed (<a href="./appendices#CD012680-sec-0094">Appendix 1</a>); </p> </li> <li> <p>Embase (<a href="./appendices#CD012680-sec-0095">Appendix 2</a>); </p> </li> <li> <p>CINAHL (<a href="./appendices#CD012680-sec-0096">Appendix 3</a>); </p> </li> <li> <p>PsycINFO (<a href="./appendices#CD012680-sec-0097">Appendix 4</a>); </p> </li> <li> <p>CENTRAL; and</p> </li> <li> <p>The Cochrane IBD Group Specialized Register.</p> </li> </ul> </p> <p>Trial registries were searched to identify any unpublished or ongoing studies. These registries included: </p> <p> <ul id="CD012680-list-0009"> <li> <p>The WHO Trials portal (ICTRP);</p> </li> <li> <p>ClinicalTrials.gov; and</p> </li> <li> <p>The EU clinical trials register.</p> </li> </ul> </p> <p>Conference proceedings were searched to identify studies published in abstract form. These conferences included: </p> <p> <ul id="CD012680-list-0010"> <li> <p>Digestive Disease Week;</p> </li> <li> <p>United European Gastroenterology Week;</p> </li> <li> <p>European Crohn’s and Colitis Organisation; and</p> </li> <li> <p>Advances in IBD.</p> </li> </ul> </p> <p>The grey literature database Open Grey was searched to identify studies not indexed in the major databases. </p> </section> <section id="CD012680-sec-0032"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of included studies and applicable systematic reviews to identify studies missed by the database searches. </p> </section> </section> <section id="CD012680-sec-0033"> <h3 class="title" id="CD012680-sec-0033">Data collection and analysis</h3> <section id="CD012680-sec-0034"> <h4 class="title">Selection of studies</h4> <p>Two authors (AMW, JP) independently screened titles and abstracts identified by the search and excluded those studies not meeting the selection criteria. Full text reports were obtained for all the studies deemed eligible and were read independently by two review authors (AMW, JP). For the studies co‐authored by AMW, eligibility was assessed by other researchers (JP, SLP). If information pertaining to eligibility was missing, we contacted the authors of the studies for further information. In cases where the two authors could not reach consensus on study eligibility, a third investigator (SLP or SK) was consulted. </p> </section> <section id="CD012680-sec-0035"> <h4 class="title">Data extraction and management</h4> <p>Data were independently extracted by two authors (AMW, JP or JP and SLP in the case of the trial co‐authored by AMW). Any disagreements were resolved by consensus and, if this could not be reached, a third author (SLP or SK) was asked to arbitrate. </p> <p>The following information was extracted:</p> <p> <ul id="CD012680-list-0011"> <li> <p>General study information: authors, year, country;</p> </li> <li> <p>Method: design (including details such as: randomisation, allocation concealment, duration, follow‐up), setting, recruitment, intervention (type of antidepressant, dose, frequency, type of controls, adherence), clinical measures (e.g. disease activity measure, measures of anxiety/depression), sample size calculation; </p> </li> <li> <p>Participants: number of participants, age, sex, IBD type, per cent in remission; and</p> </li> <li> <p>Outcomes: descriptives (mean/SD or median/inter‐quartile range (or range), frequency (%) plus accompanying statistics, e.g. OR, P value) for primary and secondary outcome measures at time points, adverse events, and loss to follow‐up. </p> </li> </ul> </p> <p>We contacted the authors of one study about missing or unclear information and the study authors provided the requested data (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>). </p> </section> <section id="CD012680-sec-0036"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two authors independently assessed the risk of bias. The variety of study designs included in this review necessitated the use of several different quality assessment tools. For RCTs, the Cochrane risk of bias tool was used (<a href="./references#CD012680-bbs2-0043" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. ">Higgins 2011</a>). The following types of bias were examined: selection bias (sequence generation and allocation sequence concealment, two items), performance bias (blinding of participants and personnel, two items), detection bias (blinding of outcome assessment, one item), attrition bias (incomplete outcome data at short‐term (two to six weeks) and at long‐term (greater than six weeks, two items), reporting bias (selective outcome reporting, one item). Each item was rated as either ‘Low risk’, ‘High risk’ or 'Unclear risk'. For observational studies (case‐control), we used the Newcastle‐Ottawa Scale (<a href="./references#CD012680-bbs2-0071" title="WellsGA , SheaB , O'ConnellD , PetersonJ , WelchV , LososM , et al. The Newcastle‐Ottawa scale (NOS) for assessing the quality of non randomised studies in meta‐analyses. www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed 13 December 2016). ">Wells 2000</a>), for which a study could score a possible of nine points, with a higher score consistent with better methodological quality. </p> <p>In addition, the GRADE approach was used to evaluate the overall quality of the evidence supporting the primary outcomes and selected secondary outcomes (<a href="./references#CD012680-bbs2-0040" title="GuyattGH , OxmanAD , VistGE , Kunz , R , Falck‐YtterY , Alonso‐CoelloP . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924‐6. ">Guyatt 2008</a>). Following the GRADE, evidence from randomised trials starts as high quality but may be downgraded due to within‐study risk of bias (methodological quality), indirect evidence, unexplained heterogeneity, imprecision of effect estimates and risk of publication bias. Evidence from non‐randomised studies starts as low quality. Each outcome was assigned one of the following scores: high quality (future research unlikely to change confidence in the estimate); moderate quality (future research likely to impact confidence in the estimate); low quality (future research very likely to impact confidence in the estimate); very low quality (the estimate is uncertain). </p> <p>Summary of findings tables were prepared for the following outcomes post‐treatment:</p> <p> <ul id="CD012680-list-0012"> <li> <p>Anxiety symptoms;</p> </li> <li> <p>Depression symptoms;</p> </li> <li> <p>Adverse events;</p> </li> <li> <p>Quality of life;</p> </li> <li> <p>Pain;</p> </li> <li> <p>Clinical remission; and</p> </li> <li> <p>Relapse.</p> </li> </ul> </p> </section> <section id="CD012680-sec-0037"> <h4 class="title">Measures of treatment effect</h4> <p>We used the RevMan software for data analysis. For dichotomous outcomes, we calculated the risk ratio (RR) and corresponding 95% confidence interval (CI). The number needed to treat (NNT) and risk difference (RD) were calculated where appropriate. For continuous outcomes, the mean difference (MD) or standardised mean difference (SMD) and corresponding 95% CI were calculated. </p> </section> <section id="CD012680-sec-0038"> <h4 class="title">Unit of analysis issues</h4> <p>Where the efficacy of multiple antidepressants (on IBD activity) was meant to be compared, it was planned to split the shared comparison group (e.g. standard care or psychotherapy) equally between the antidepressants arms as comparison groups. However, such a study was not identified. Cross‐over trials were to be included only when antidepressant and comparator data were extracted from the first treatment period or when the sufficient wash‐out period occurred between treatment periods (e.g. two weeks for all antidepressants except for fluoxetine where four weeks are required in light of the long plasma half‐life). However, no cross‐over trial was identified. SE was converted into SD using the following formula: SD = SE / √1/N<sub>E</sub>+1/N<sub>C</sub>. </p> </section> <section id="CD012680-sec-0039"> <h4 class="title">Dealing with missing data</h4> <p>Where possible, the intention‐to‐treat principle was adhered to. In the case of dichotomous data when treatment response was compared, the total number of participants in each pre‐treatment comparison group (as the denominator) was included. In the analyses of treatment response, only the data from studies reporting a group size prior to drop‐outs were included. For continuous outcome measures, we included summary statistics derived from (in order of preference) mixed‐effects models, observed cases summary statistics, and last observation carried forward where possible. This was dictated by the notion that mixed‐effects models are considered less biased than the analyses of the last observation carried forward (<a href="./references#CD012680-bbs2-0069" title="VerbekeM , MolenberghsG . Linear Mixed Models for Longitudinal Data. 2nd Edition. New York: Springer, 2000. ">Verbeke 2000</a>). </p> </section> <section id="CD012680-sec-0040"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned to assess clinical homogeneity using the forest plot of the risk ratio. We also planned to review the results of the Chi<sup>2</sup> test. A P value of less than 0.10 was to be considered evidence of statistically significant heterogeneity (assuming the low power of the Chi<sup>2</sup> statistic when few trials are available) (<a href="./references#CD012680-bbs2-0029" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). This proved impractical due to the very small number of studies identified. </p> <p>The I<sup>2</sup> statistic was used to assess heterogeneity across trials (<a href="./references#CD012680-bbs2-0042" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>). An I<sup>2</sup> statistic greater than 30% was considered moderate heterogeneity and greater than 50% was considered severe heterogeneity. </p> <p>Subgroup differences in continuous measures of antidepressant efficacy were to be investigated using Deeks' stratified test of heterogeneity (<a href="./references#CD012680-bbs2-0027" title="DeeksJJ , AltmanDG , BradburnMJ . Statistical methods for examining heterogeneity and combining results from several studies in meta‐analysis. In: EggerM , DaveySG , AltmanDG editor(s). Systematic Reviews in Health Care: Meta‐Analysis in Context. BMJ Publication Group, 2001. ">Deeks 2001</a>). Herein the sum of the Chi<sup>2</sup> statistics for each of the subgroups included in the study is subtracted from the Chi<sup>2</sup> statistic for all the studies, to provide a measure (Qb) of heterogeneity between groups. As different antidepressants may exert different effects, we planned to stratify all of the outcome comparisons by the individual antidepressant used (excluding subgroup and sensitivity analyses). This however proved impossible due to each study using a different type of antidepressant. </p> </section> <section id="CD012680-sec-0041"> <h4 class="title">Assessment of reporting biases</h4> <p>Small‐sample effects were to be investigated by visual inspection of a funnel plot of treatment response (<a href="./references#CD012680-bbs2-0064" title="SterneJA , EggerM , MoherD . Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Sterne 2011</a>). This was however deemed inappropriate as we identified fewer than 10 studies and the method is not robust in such cases (<a href="./references#CD012680-bbs2-0030" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315(7109):629‐34. ">Egger 1997</a>). </p> </section> <section id="CD012680-sec-0042"> <h4 class="title">Data synthesis</h4> <p>The pooled RR and corresponding 95% CI was calculated for dichotomous outcomes. For continuous outcomes, the pooled MD or SMD with 95% CI was calculated as appropriate. It was planned to combine dichotomous and continuous variables using the standard Cochrane procedure (InOR = SMD X π / √ 3) (<a href="./references#CD012680-bbs2-0029" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>), but this proved unnecessary. We obtained categorical and continuous treatment effects using a fixed‐effect model. The outcomes were expressed as an average effect size for each subgroup and 95% CIs. In some models, heterogeneity was present and in such cases random‐effects models are usually preferred. However, the Cochrane Handbook does warn that if the effect size is associated with sample size, then using a random‐effects model will award relatively more weight to the smaller studies, and will exacerbate bias (<a href="./references#CD012680-bbs2-0029" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). This is further confirmed by a recent evidence synthesis (<a href="./references#CD012680-bbs2-0020" title="BenderR , FriedeT , KochA , KussO , SchlattmannP , SchwarzerG , SkipkaG . Methods for evidence synthesis in the case of very few studies. Research Synthesis Methods2018;9:382–92. ">Bender 2018</a>). As this review includes a small number of studies, a fixed‐effect model was applied for the analyses. </p> </section> <section id="CD012680-sec-0043"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Subgroup analysis was to be conducted for the following subgroups:</p> <p>IBD subtype: Crohn's disease versus ulcerative colitis or indeterminate colitis;</p> <p>Sex: Male versus female; and</p> <p>Types of antidepressants: SSRI versus tricyclics.</p> <p>This was not deemed practical due to the small number of studies.</p> </section> <section id="CD012680-sec-0044"> <h4 class="title">Sensitivity analysis</h4> <p>Sensitivity analysis was to be performed to check the robustness of our conclusions for the meta‐analysis of the primary outcome. We planned to follow the same procedure as was applied in our previous protocol on a similar topic (<a href="./references#CD012680-bbs2-0037" title="GordonA , Mikocka‐WalusA , GrzeskowiakLE , JayasekaraRS . Antidepressants for depression during pregnancy. Cochrane Database of Systematic Reviews2013, Issue 8. [DOI: 10.1002/14651858.CD010710] ">Gordon 2013</a>): </p> <p>We planned to assess whether treatment response varies as a function of the use of treatment response versus non‐response as outcomes. Treatment response may produce less consistent outcome statistics than non‐response in cases when the control group event rate is greater than 50% (<a href="./references#CD012680-bbs2-0028" title="DeeksJJ . Issues in the selection of a summary statistic for meta‐analysis of clinical trials with binary outcomes. Statistics in Medicine2002;21(11):1575‐1600. ">Deeks 2002</a>). This analysis was only to be conducted if the majority of studies reported a control group event rate greater than 50%. This was not the case for the analysis. </p> <p>Conducting a 'worst case/best case' analysis was considered to examine the impact of the exclusion of those lost to follow‐up on treatment efficacy effect estimates (<a href="./references#CD012680-bbs2-0029" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). Herein, for the worst case scenario, all the missing data for the treatment group were to be recorded as non‐responders. For the best case scenario, all missing data in the control group were to be considered non‐responders. Where the effect estimates of treatment efficacy would not differ between these two comparisons, it would be concluded that missing data in the studies did not have a marked impact on outcomes. This analysis was to be done in case we had access to full data sets for the included studies. This was the case for one study only (<a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012680-sec-0045" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012680-sec-0045"></div> <section id="CD012680-sec-0046"> <h3 class="title">Description of studies</h3> <section id="CD012680-sec-0047"> <h4 class="title">Results of the search</h4> <p>The search was conducted on 23 August 2018 and identified 3920 records. After duplicates were removed, 3144 records were screened for inclusion. Of the studies that were screened, 16 were selected for full text review. Overall, 4 studies met the inclusion criteria (<a href="#CD012680-fig-0001">Figure 1</a>). No additional studies were identified through other sources. </p> <div class="figure" id="CD012680-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012680-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012680-sec-0048"> <h4 class="title">Included studies</h4> <section id="CD012680-sec-0049"> <h5 class="title">Country</h5> <p>Included studies came from four countries: one each conducted in Australia (<a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>), Iran (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>), Poland (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>) and the United Kingdom (<a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>). </p> </section> <section id="CD012680-sec-0050"> <h5 class="title">Study design</h5> <p>The search identified two double blind RCTs (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>), one non‐randomised controlled trial (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>), and one observational retrospective case‐matched study (<a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>). </p> </section> <section id="CD012680-sec-0051"> <h5 class="title">Participant characteristics</h5> <p>The studies included a total of 188 patients with IBD (96 assigned to intervention and 93 assigned to controls). The age of participants ranged from 27 (<a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>) to 37.8 years (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>). The proportion of female participants ranged from 46% (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>) to 65% (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>). In three studies participants were in IBD remission (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>) and in one study participants had mixed IBD activity (<a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>). In one study participants had to have co‐morbid symptoms of anxiety and/or depression (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>) while in the remaining studies this was not part of the inclusion criteria. Two studies included both participants with Crohn's disease and ulcerative colitis (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>), one study included only participants with Crohn's disease (<a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>) and another only those with ulcerative colitis (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>). </p> </section> <section id="CD012680-sec-0052"> <h5 class="title">Treatment</h5> <p>In the experimental groups, one study used duloxetine 60 mg daily (an SNRI antidepressant) (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>), one study used fluoxetine 20 mg daily (an SSRI antidepressant) (<a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>), one study used tianeptine 12 mg three times a day (an atypical antidepressant) (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>), and one study used various antidepressants in clinical ranges (<a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>). Three studies used a placebo control (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>), and one study used a no treatment control group matched for various clinical and demographic characteristics (<a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>). </p> </section> <section id="CD012680-sec-0053"> <h5 class="title">Follow‐up</h5> <p>The follow‐up periods ranged from 12 weeks to 12 months, with one study (<a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>) observing participants 12 months before and 12 months after being prescribed an antidepressant. In two studies no attrition was recorded (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>), while in one study 79% of participants remained in the study at 12‐weeks of follow‐up (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>), and in another study 69% of participants remained in the study at 12‐months of follow‐up (<a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). </p> </section> <section id="CD012680-sec-0054"> <h5 class="title">Outcome measures</h5> <p>In terms of the primary outcome measures, three studies measured symptoms of anxiety and depression (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). Symptoms of anxiety and depression were measured using the Hospital Anxiety and Depression Scale (HADS) in two studies (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>), and the Hamilton Anxiety Rating Scale (HARS) and the Beck Depression Inventory (BDI) in one study (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>). </p> <p>Regarding the secondary outcome measures, three studies measured adverse events (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>), two studies measured study withdrawal due to adverse events and QoL (<a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>; <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>). All studies measured IBD activity. Three studies used an IBD activity index (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>), two studies used blood tests ( <a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>), one study used faecal calprotectin (<a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>), and one study used endoscopy (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>). </p> <p>QoL was measured using the World Health Organization Quality of Life (WHOQOL‐BREF) questionnaire (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). The WHOQOL‐BREF is a short version of the World Health Organization Quality of Life (WHOQOL‐100) questionnaire and is a tool which can be used cross‐culturally to evaluate quality of life (<a href="./references#CD012680-bbs2-0072" title="The WHOQOL Group. Development of the World Health Organization WHOQOL‐BREF quality of life assessment. Psychological Medicine1998;28(3):551‐8. ">WHOQOL‐BREF</a>). WHOQOL‐BREF measures four major domains of QoL: physical (corresponding with physical health, e.g. fatigue, pain, sleep), psychological (corresponding with psychological well‐being, e.g. self‐esteem, body image, positive or negative feelings), social relationships (corresponding with personal relationships, social support and sexual functioning) and environment (corresponding with people's relationship to their environment, e.g. safety, financial resources, transport, physical environment). </p> <p>Disease activity indices included the Crohn's Disease Activity Index (CDAI) (<a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>), the Lichtiger Colitis Activity Index (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>), and the Mayo Clinic Disease Activity Index (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>). The blood tests included C‐reactive protein (CRP) (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>), and cytokines/chemokines (<a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). </p> <p>One study measured hospital admissions and need for steroid treatment (<a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>). None of the studies measured pain or surgery. </p> <p>For details of studies see <a href="./references#CD012680-sec-0105" title="">Characteristics of included studies</a>. </p> </section> </section> <section id="CD012680-sec-0055"> <h4 class="title">Excluded studies</h4> <p>Studies were excluded for not meeting the inclusion criteria of study design (<a href="./references#CD012680-bbs2-0005" title="DrossmanDA . Treatment of residual inflammatory bowel disease symptoms with low‐dose tricyclic antidepressants: why not?. Journal of Clinical Gastroenterology2014;48:390‐2. ">Drossmann 2014</a>; <a href="./references#CD012680-bbs2-0006" title="EirundW . Positive attendant effects of Paroxetin in Colitis ulcerosa. Psychiatrische Praxis1998;25(1):49. ">Eirund 1998</a>), presenting data overlapping with another paper (<a href="./references#CD012680-bbs2-0008" title="IskandarH , CassellB , CiorbaM , SayukG . Tricyclic antidepressants in the management of IBD patients with functional GI symptoms. American Journal of Gastroenterology2012;107:717. ">Iskandar 2012</a>; <a href="./references#CD012680-bbs2-0007" title="IskandarH , KanuriN , KassopoulosT , GutierrezA , CiorbaM , SayukG . The efficacy of antidepressant medications in management of IBD patients with functional GI symptoms. Inflammatory Bowel Diseases2011;17:17. ">Iskandar 2011</a>), lack of information regarding the efficacy of antidepressants (<a href="./references#CD012680-bbs2-0010" title="LoftusEV , GuerinA , YuAP , WuEQ , YangM , ChaoJ , et al. Increased risks of developing anxiety and depression in young patients with Crohn's disease. American Journal of Gastroenterology2011;106:1670‐77. ">Loftus 2011</a>; <a href="./references#CD012680-bbs2-0014" title="VirtaLJ , KolhoKL . Antidepressant use among paediatric patients with recent‐onset inflammatory bowel disease: A nationwide case control study in Finland. Journal of Paediatrics and Child Health2014;50:562‐5. ">Virta 2014</a>), including combination therapy without separate data on antidepressant efficacy (<a href="./references#CD012680-bbs2-0015" title="XieR , GaoC , WuS , YanW , MaT . Clinical observation of flupentixol and melitracen combined with mesalazine for treatment of ulcerative colitis patients with anxiety and depression. Chinese Journal of Gastroenterology2014;19(10):599‐602. ">Xie 2014</a>; <a href="./references#CD012680-bbs2-0013" title="NCT02162862 . Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease. Clinicaltrials.gov/show/NCT02162862 (accessed 31 January 2018). ">NCT02162862</a>), no validated measure of outcomes (<a href="./references#CD012680-bbs2-0011" title="Mikocka‐WalusA , AndrewsJM . Experience with and attitudes toward psychotherapy and antidepressants among patients with inflammatory bowel disease and functional gastrointestinal disorders. Gastroenterology Nursing2016b;39(4):278‐86. ">Mikocka‐Walus 2016b</a>), no control group (<a href="./references#CD012680-bbs2-0016" title="YantarasO , KaniHC , BicakciE , BezY , BanzragchM , SenkalZ , et al. The effects of psychiatric treatment in patients with inflammatory bowel disease: a prospective study. Journal of Crohn's and Colitis2016; Vol. 10:S314‐S5. ">Yanartas 2016</a>), a control group not comprised of IBD patients (<a href="./references#CD012680-bbs2-0009" title="IskandarHN , CassellB , KanuriN , GyawaliCP , GutierrezA , DassopoulosT , et al. Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease. Journal of Clinical Gastroenterology2014;48(5):423‐9. ">Iskandar 2014</a>), and a trial registration without published results (<a href="./references#CD012680-bbs2-0012" title="NCT00126373 . A Trial of Wellbutrin for Crohn's Disease. Clinicaltrials.gov/show/NCT00126373 (accessed 31 January 2018). ">NCT00126373</a>). See <a href="./references#CD012680-sec-0106" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD012680-sec-0056"> <h3 class="title">Risk of bias in included studies</h3> <p>The results of the risk of bias analysis for the three controlled trials are summarized in <a href="#CD012680-fig-0002">Figure 2</a> and <a href="#CD012680-fig-0003">Figure 3</a> (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). <a href="#CD012680-tbl-0002">Table 1</a> reports the Newcastle‐Ottawa Scale results for the observational study (<a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>). <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a> was rated as low risk of bias. <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a> was rated as high risk of bias for incomplete outcome data. The non‐randomised controlled trial was associated with low risk of bias on two items, unclear risk on two items (blinding of outcome assessment and selective reporting) and high risk on three items (random sequence generation, allocation concealment, blinding of participants and personnel) (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>). </p> <div class="figure" id="CD012680-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012680-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD012680-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012680-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="table" id="CD012680-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Newcastle‐Ottawa Scale results for observational study by Goodhand 2012</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case Control Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Is the case definition adequate? (/1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Representativeness of the cases (/1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Selection of controls (/1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Definition of controls (/1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comparability of cases and controls on the basis of the design or analysis (/2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assessment of exposure (/1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Same method of ascertainment for cases and controls (/1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐Response Rate (/1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Goodhand (2012)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> </tr> </tbody> </table> </div> <p>The observational study (<a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>), was considered to be of reasonable methodological quality and was given a score of seven stars. However, there were concerns with two items: representativeness of the cases and definition of controls. Cases were not completely representative as some of them were excluded based on the lack of data (e.g. when the date of commencement of the antidepressant was missing). The definition of controls was considered incomplete as it did not mention the history of outcome in this group. Importantly, this study was non‐randomised and as such is likely to be associated with a higher risk of bias than RCTs. </p> <section id="CD012680-sec-0057"> <h4 class="title">Allocation</h4> <p>Random sequence generation was rated as low risk of bias in two studies (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>), and as high risk in the non‐randomised controlled trial (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>). Allocation concealment was rated as high risk of bias in one study (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>), as low risk in two studies (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). </p> </section> <section id="CD012680-sec-0058"> <h4 class="title">Blinding</h4> <p>Blinding of participants and personnel was judged to be adequate in two studies (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>), and high risk of bias in one study (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>). Blinding of outcome assessment was judged to be adequate in two studies (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>), and unclear risk of bias in one study (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>). </p> </section> <section id="CD012680-sec-0059"> <h4 class="title">Incomplete outcome data</h4> <p>One study was judged to be at high risk of bias for Incomplete outcome data (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>), while two studies were judged to be at low risk of bias for this item (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). </p> </section> <section id="CD012680-sec-0060"> <h4 class="title">Selective reporting</h4> <p>Selective reporting was considered at low risk of bias in two studies (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>), and unclear risk of bias in one study (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>). </p> </section> <section id="CD012680-sec-0061"> <h4 class="title">Other potential sources of bias</h4> <p>The three trials were considered at low risk of bias for other types of bias (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>) . </p> </section> </section> <section id="CD012680-sec-0062"> <h3 class="title" id="CD012680-sec-0062">Effects of interventions</h3> <p>See: <a href="./full#CD012680-tbl-0001"><b>Summary of findings for the main comparison</b> Antidepressants compared to placebo for inflammatory bowel disease</a> </p> <section id="CD012680-sec-0063"> <h4 class="title"><i>Comparison 1: Antidepressants versus placebo</i> </h4> <p>Overall, four studies have contributed to this comparison (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). </p> <section id="CD012680-sec-0064"> <h5 class="title">Primary outcome measures</h5> </section> <section id="CD012680-sec-0065"> <h5 class="title">Anxiety</h5> <p>Three studies examined the effect of antidepressants on symptoms of anxiety (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). </p> <p>At 12 weeks, using the HADS, <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a> reported a mean score of 6.11 + 3 in the antidepressant group (n = 22) compared to 8.5 + 3.45 in the placebo group (n = 22) (MD ‐2.39, 95% ‐4.30 to ‐0.48; low certainty evidence, see <a href="./references#CD012680-fig-0004" title="">Analysis 1.1</a> and <a href="./full#CD012680-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>At 12 months, two trials reported that symptoms of anxiety were improved in participants receiving antidepressants compared to placebo (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). We initially attempted to pool these studies using the SMD but a very high degree of heterogeneity was detected (I<sup>2</sup>= 87%). Thus we report the results for each trial separately. Using the HARS, <a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a> reported a mean score of 12.65 + 3.76 in the antidepressant group (n = 30) compared to 17.85 + 3.33 in the placebo group (n = 30) (MD ‐5.20, 95% CI ‐7 to ‐3.40; very low certainty evidence). Using the HADS, <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a> reported a mean score of 3.8 + 2.5 in the antidepressant group (n = 14) compared to 4.2 + 4.9 in the placebo group (n = 12) (MD ‐0.40, 95% ‐3.47 to 2.67, low certainty evidence; See <a href="./references#CD012680-fig-0005" title="">Analysis 1.2</a> and <a href="./full#CD012680-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD012680-sec-0066"> <h5 class="title">Depression</h5> <p>Three studies examined the effect of antidepressants on symptoms of depression (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). </p> <p>At 12 weeks, using the HADS, <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a> reported a mean score of 7.47 + 2.42 in the antidepressant group (n = 22) compared to 10.5 + 3.57 in the placebo group (n = 22) (MD ‐3.03, 95% CI ‐4.83 to ‐1.23, low certainty evidence; see <a href="./references#CD012680-fig-0006" title="">Analysis 1.3</a> and <a href="./full#CD012680-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>At 12 months, two trials reported that symptoms of depression were improved in participants receiving antidepressants compared to placebo (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). We initially attempted to pool these studies using the SMD but a very high degree of heterogeneity was detected (I<sup>2</sup>= 89%). Thus we report the results for each trial separately. Using the BDI, <a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a> reported a mean score of 9.6 + 2.76 in the antidepressant group (n = 30) compared to 16.35 + 5.41 in the placebo group (n = 30) (MD ‐6.75, 95% CI ‐8.92 to ‐4.58; very low certainty evidence). Using the HADS, <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a> reported a mean score of 2.9 + 2.8 in the antidepressant group (n = 14) compared to 3.1 + 3.4 in the placebo group (n = 12) (MD ‐0.20, 95% ‐2.62 to 2.22, low certainty evidence; See <a href="./references#CD012680-fig-0007" title="">Analysis 1.4</a> and <a href="./full#CD012680-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> </section> <section id="CD012680-sec-0067"> <h4 class="title">Secondary outcome measures</h4> <section id="CD012680-sec-0068"> <h5 class="title">Adverse events</h5> <p>Adverse events were reported in three studies, with nausea being an adverse event common to all three studies (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). </p> <p>At 12 weeks, higher rates of nausea were reported in the antidepressant group compared to placebo (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>). Thirty‐two per cent (7/22) of participants in the antidepressant group reported nausea compared to nine per cent (2/22) of placebo participants (RR 3.50, 95% CI 0.82 to 15.01; very low certainty evidence). The very low GRADE rating was due to a small sample size and incomplete outcome data. </p> <p>At 12 months, two trials showed no group difference in nausea between those taking antidepressants and placebo (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). Thirteen per cent (6/44) of those taking antidepressants reported nausea compared to two per cent (1/42) of placebo participants (RR 4.02, 95% CI 0.74 to 22.03). </p> <p>Adverse events in the group who received antidepressants included nausea, headache, dizziness, drowsiness, sexual problems, insomnia, fatigue, low mood/anxiety, dry mouth, poor sleep, restless legs and hot flushes. Adverse events in the control group included dizziness, insomnia and muscle spasms (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). </p> <p><a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a> reported on the number of participants who had an adverse event. Fifty‐seven per cent (8/14) of those in the antidepressant group reported adverse events compared to 25% (3/12) of the placebo group (RR 2.29, 95% CI 0.78 to 6.73, low certainty evidence; See <a href="./references#CD012680-fig-0008" title="">Analysis 1.5</a> and <a href="./full#CD012680-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD012680-sec-0069"> <h5 class="title">Serious adverse events</h5> <p>Serious adverse events were not reported by the included studies.</p> </section> <section id="CD012680-sec-0070"> <h5 class="title">Study withdrawal due to adverse events</h5> <p>One RCT examined the effect of antidepressants on study withdrawal due to adverse events at 12 weeks (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>), and one RCT examined the effect of antidepressants on study withdrawal due to adverse events at 12 months (<a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). </p> <p>At 12 weeks, no group difference in study withdrawal due to adverse events was observed, with 4% (1/22) of participants taking antidepressants withdrawing from the study due to adverse events (adverse event type not reported) compared to 0% (0/22) of placebo group participants (RR 3, 95% CI 0.13 to 69.9; see <a href="./references#CD012680-fig-0011" title="">Analysis 1.8</a>). </p> <p>At 12 months, no group difference in study withdrawal due to adverse events was observed, with 7% (1/14) of participant taking antidepressants withdrawing from the study due to adverse events (including poor sleep, anxiety, restless legs) compared to 0% (0/12) of placebo group participants (RR 2.6, 95% CI 0.12 to 58.5; see <a href="./references#CD012680-fig-0012" title="">Analysis 1.9</a>). </p> </section> <section id="CD012680-sec-0071"> <h5 class="title">Quality of life</h5> <p>One RCT examined the effect of antidepressants on QoL at 12 weeks (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>) and one RCT examined the effect of antidepressants on QoL at 12 months (<a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). Both studies used the WHOQOL‐BREF questionnaire. </p> <section id="CD012680-sec-0072"> <h6 class="title">Physical QoL</h6> <p>At 12 weeks, <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a> reported a mean score of 60.24 + 12.94 in the antidepressant group (n = 22) compared to 49.52 + 10.12 in the placebo group (n = 22) (MD 10.72, 95% CI 3.86 to 17.58, low certainty evidence; See <a href="./references#CD012680-fig-0013" title="">Analysis 1.10</a> and <a href="./full#CD012680-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>At 12 months, <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a> reported a mean score of 68.83 + 13.34 in the antidepressant group (n = 14) compared to 66.66 + 21.72 in the placebo group (n = 12) (MD 2.17, 95% CI ‐11.97 to 16.31, low certainty evidence; See <a href="./references#CD012680-fig-0014" title="">Analysis 1.11</a> and <a href="./full#CD012680-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD012680-sec-0073"> <h6 class="title">Psychological QoL</h6> <p>At 12 weeks, <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a> reported a mean score of 51.81 + 13.6 in the antidepressant group (n = 22) compared to 43.5 + 11.94 in the placebo group (n = 22) (MD 8.31, 95% CI 0.75 to 15.87, low certainty evidence; See <a href="./references#CD012680-fig-0015" title="">Analysis 1.12</a> and <a href="./full#CD012680-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>At 12 months, <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a> reported a mean score of 75.37 + 14.84 in the antidepressant group (n = 14) compared to 72.22 + 16.79 in the placebo group (n = 12) (MD 3.15, 95% CI ‐9.12 to 15.42, low certainty evidence; See <a href="./references#CD012680-fig-0016" title="">Analysis 1.13</a> and <a href="./full#CD012680-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD012680-sec-0074"> <h6 class="title">Social QoL</h6> <p>At 12 weeks, <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a> reported a mean score of 51.2 + 15.1 in the antidepressant group (n = 22) compared to 38.88 + 12.12 in the placebo group (n = 22) (MD 12.32, 95% CI 4.23 to 20.41, low certainty evidence; See <a href="./references#CD012680-fig-0017" title="">Analysis 1.14</a> and <a href="./full#CD012680-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>At 12 months, <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a> reported a mean score of 73.48 + 18.56 in the antidepressant group (n = 14) compared to 75 + 23.19 in the placebo group (n = 12) (MD ‐1.52, 95% CI ‐17.85 to 14.81, low certainty evidence; See <a href="./references#CD012680-fig-0018" title="">Analysis 1.15</a> and <a href="./full#CD012680-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD012680-sec-0075"> <h6 class="title">Environmental QoL</h6> <p>At 12 weeks, <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a> reported a mean score of 51.79 + 10.24 in the antidepressant group (n = 22) compared to 44.13 + 12.27 in the placebo group (n = 22) (MD 7.66, 95% CI 0.98 to 14.34, low certainty evidence; See <a href="./references#CD012680-fig-0019" title="">Analysis 1.16</a> and <a href="./full#CD012680-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>At 12 months, <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a> reported a mean score of 73.86 + 14.41 in the antidepressant group (n = 14) compared to 75.69 + 9.85 in the placebo group (n = 12) (MD ‐1.83, 95% CI ‐11.21 to 7.55; low certainty evidence; See <a href="./references#CD012680-fig-0020" title="">Analysis 1.17</a> and <a href="./full#CD012680-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>The low GRADE rating at both 12 weeks and 12 months was due to very serious imprecision (26 participants) in one study (<a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>), and incomplete outcome data and imprecision (44 participants) in the other study (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>). </p> </section> </section> <section id="CD012680-sec-0076"> <h5 class="title">Clinical remission</h5> <p>One trial reported on remission rates at 12 months post treatment (<a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). In the group receiving an antidepressant, 64% (9/14) of participants remained in remission (based on CDAI and faecal calprotectin) compared to 66% (8/12) in the placebo group (RR 0.96, 95% CI 0.55 to 1.69, low certainty evidence; see <a href="./references#CD012680-fig-0021" title="">Analysis 1.18</a> and <a href="./full#CD012680-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>Three studies used a disease activity index to measure disease activity (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). This post hoc outcome was not pre‐specified in our protocol. </p> <p>At 12 weeks, using the Lichtiger Colitis Activity Index, <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a> reported a mean score of 4.52 + 11.63 in the antidepressant group (n = 22) compared to 6.83 + 2.09 in the placebo group (n = 22) (MD ‐2.31, 95% CI ‐3.42 to ‐1.20; See <a href="./references#CD012680-fig-0022" title="">Analysis 1.19</a>). </p> <p>At 12 months, two trials reported that disease activity was improved in the group taking antidepressants as compared to placebo (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). We initially attempted to pool these studies using the SMD but a very high degree of heterogeneity was detected (I<sup>2</sup>= 87%). Thus we report the results for each trial separately. Using the Mayo Clinic Disease Activity Index, <a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a> reported a mean score of 3.05 + 1.36 in the antidepressant group (n = 30) compared to 4.65 + 1.69 in the placebo group (n = 30) (MD ‐1.60, 95% CI ‐2.38 to ‐0.82; See <a href="./references#CD012680-fig-0023" title="">Analysis 1.20</a>). Using the CDAI, <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a> reported a mean score of 84.4 + 82.5 in the antidepressant group compared (n = 14) to 60.63 + 46.5 in the placebo group (n = 12) (MD 23.77, 95% CI ‐26.82 to 74.36; See <a href="./references#CD012680-fig-0023" title="">Analysis 1.20</a>). </p> <p>No study collected data on clinical remission at longitudinal follow‐up beyond trial completion. </p> </section> <section id="CD012680-sec-0077"> <h5 class="title">Relapse</h5> <p>One non‐randomised trial reported on endoscopic relapse up to 12 months post treatment (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>). At 12 months, 0% (0/30) of participants in the antidepressant group had endoscopic relapse compared to 10% (3/30) of placebo group participants (RR 0.14, 95% CI 0.01 to 2.65, very low certainty evidence; see <a href="./references#CD012680-fig-0024" title="">Analysis 1.21</a> and <a href="./full#CD012680-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>The following relevant post hoc outcomes were not pre‐specified in our review protocol: relapse using clinician's assessment, faecal calprotectin and blood tests (CRP, cytokines/chemokines). </p> <p><a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a> reported on the number of relapses (clinician assessed based on symptoms/blood tests) in the year preceding treatment with antidepressants and in the year after the treatment commenced. In the year after starting an antidepressant, patients treated with an antidepressant had fewer relapses than controls (median[range] = 0 [0–4) versus 1 [0–3]). </p> <p>In one trial (<a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>) there was no group difference in the relapse rate as measured using faecal calprotectin at 12 months (post treatment), with 7% (1/14) of the participants in the antidepressant group relapsing (faecal calprotectin &gt; 200) compared to 0% (0/12) of the placebo group (MD 2.60, 85% CI 0.12 to 58.48; See <a href="./references#CD012680-fig-0025" title="">Analysis 1.22</a>). </p> <p>Regarding blood tests, one trial reported data on CRP (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>), while another trial reported data for cytokines and chemokines (<a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). <a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a> reported a mean CRP of 6.99 + 5.65 in the antidepressant group (n = 30) compared to 9.40 + 6.78 in the placebo group (n = 30) (MD ‐2.41, 95% CI ‐5.57 to 0.75; See <a href="./references#CD012680-fig-0026" title="">Analysis 1.23</a>). </p> <p><a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a> reported a mean proportion of TH Effector Memory RA cells of 45.8 + 4.5 in the antidepressant group (n = 14) compared to 39.7 + 3.1 in the placebo group (n = 12) (MD 6.10, 95% CI 3.16 to 9.04; See <a href="./references#CD012680-fig-0027" title="">Analysis 1.24</a>). </p> <p><a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a> reported a mean proportion of TC Effector Memory RA cells of 3.5 + 0.48 in the antidepressant group (n = 14) compared to 4.75 + 0.9 in the placebo group (n = 12) (MD ‐1.25, 95% CI ‐1.82 to ‐0.68; See <a href="./references#CD012680-fig-0028" title="">Analysis 1.25</a>). </p> <p>Regarding interleukin‐10 (IL‐10) secretion, <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a> reported a mean of CD3/CD28 stimulated cytokine concentrations in peripheral blood mononuclear cells supernatants of 525.3 + 93.2 in the antidepressant group (n = 14) compared to 222.9 + 63.2 in the placebo group (n = 12) (MD 302.4, 95% CI 241.89 to 362.91; See <a href="./references#CD012680-fig-0029" title="">Analysis 1.26</a>). </p> <p>No study collected data on relapse at longitudinal follow‐up beyond trial completion.</p> </section> <section id="CD012680-sec-0078"> <h5 class="title">Pain severity</h5> <p>None of the included studies examined the impact of antidepressants on pain.</p> </section> <section id="CD012680-sec-0079"> <h5 class="title">Hospital admissions</h5> <p>Hospital admissions were included as an outcome in only one study (<a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>), and thus a meta‐analysis was not conducted. At 12‐month follow‐up, no participants in either group had hospital admissions due to IBD. </p> </section> <section id="CD012680-sec-0080"> <h5 class="title">Surgery</h5> <p>The included studies did not examine the impact of antidepressants on the need for surgery. </p> </section> <section id="CD012680-sec-0081"> <h5 class="title">Need for steroid treatment</h5> <p>The need for steroid treatment was included as an outcome in only one study (<a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>). At 1‐year follow‐up, no participants in the antidepressant group (0/29) required steroids compared to 3% (1/29) of those in the control group (MD 0.33, 95% CI 0.01 to 7.86; See <a href="./references#CD012680-fig-0030" title="">Analysis 1.27</a>). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012680-sec-0082" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012680-sec-0082">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012680-sec-0136">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012680-sec-0082"></div> <p>Up to 30% of people with IBD take antidepressants (<a href="./references#CD012680-bbs2-0034" title="Fuller‐ThomsonE , SulmanJ . Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflammatory Bowel Diseases2006;12(8):697‐707. ">Fuller‐Thomson 2006</a>; <a href="./references#CD012680-bbs2-0041" title="HaapamakiJ , TanskanenA , RoineRP , BlomM , TurunenU , MantylaJ , et al. Medication use among inflammatory bowel disease patients: excessive consumption of antidepressants and analgesics. Scandinavian Journal of Gastroenterology2013;48(1):42‐50. ">Haapamaki 2013</a>; <a href="./references#CD012680-bbs2-0053" title="Mikocka‐WalusAA , GordonAL , StewartBJ , AndrewsJM . The role of antidepressants in the management of inflammatory bowel disease (IBD): a short report on a clinical case‐note audit. Journal of Psychosomatic Research2012;72(2):165‐7. ">Mikocka‐Walus 2012</a>). Despite the clinical relevance of the present topic, there were only four studies (examining 188 people in total) of sufficient quality to include in this systematic review. </p> <p>The review cautiously suggests that antidepressants improved the symptoms of anxiety and depression. There was no group difference in nausea or study withdrawal due to adverse events. Antidepressants were associated with some benefits for QoL and disease activity. However, the GRADE analysis indicated that the overall certainty of the evidence was very low, due to a small sample size, incomplete outcome data, and heterogeneity in population and antidepressant treatment type, thus more well‐designed studies are needed. Future trials examining the role of antidepressants in IBD are therefore needed to clarify whether the present findings are consistent. </p> <section id="CD012680-sec-0083"> <h3 class="title" id="CD012680-sec-0083">Summary of main results</h3> <p>Up to 30% of people with IBD take antidepressants (<a href="./references#CD012680-bbs2-0034" title="Fuller‐ThomsonE , SulmanJ . Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflammatory Bowel Diseases2006;12(8):697‐707. ">Fuller‐Thomson 2006</a>; <a href="./references#CD012680-bbs2-0041" title="HaapamakiJ , TanskanenA , RoineRP , BlomM , TurunenU , MantylaJ , et al. Medication use among inflammatory bowel disease patients: excessive consumption of antidepressants and analgesics. Scandinavian Journal of Gastroenterology2013;48(1):42‐50. ">Haapamaki 2013</a>; <a href="./references#CD012680-bbs2-0053" title="Mikocka‐WalusAA , GordonAL , StewartBJ , AndrewsJM . The role of antidepressants in the management of inflammatory bowel disease (IBD): a short report on a clinical case‐note audit. Journal of Psychosomatic Research2012;72(2):165‐7. ">Mikocka‐Walus 2012</a>). Despite the clinical relevance of the present topic, there were only four studies (including 188 participants) meeting the inclusion criteria (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>; <a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). Two studies were double‐blind RCTs (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). One study was non‐randomised controlled trial (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>), and the final study was an observational retrospective case‐matched study (<a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>). </p> <p>Symptoms of anxiety and depression were improved at 12 weeks and 12 months in antidepressant participants compared to placebo. There were no group differences in adverse events at 12 months or study withdrawal due to adverse events at 12 weeks or 12 months. Physical, Psychological, Social and Environmental QoL were improved at 12 weeks with no group differences at 12 months. Disease activity as measured by disease activity indices was also improved in the group receiving antidepressants. However, there was no group difference in clinical remission at 12 months (based on the CDAI and faecal calprotectin), or relapse rate at 12 months (based on endoscopy or faecal calprotectin). There were no group differences in hospital admissions or need for steroid treatment. Pain severity or surgery were not reported in the included studies. </p> </section> <section id="CD012680-sec-0084"> <h3 class="title" id="CD012680-sec-0084">Overall completeness and applicability of evidence</h3> <p>The results of this review are applicable to adults with Crohn's disease and ulcerative colitis, though at this point it is unclear if patients with either IBD subtype may benefit more from antidepressant treatment. The studies included in this review assessed different IBD populations. For example, one study limited the intervention to the participants reporting symptoms of anxiety and depression (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>), while the other studies did not. One study included participants with mixed disease activity (<a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>), while the other studies included participants who were in remission. Two studies included participants with Crohn's disease and ulcerative colitis (<a href="./references#CD012680-bbs2-0002" title="DaghaghzadehH , NajiF , AfsharH , SharbafchiMR , FeiziA , MaroufiM , et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double‐blind controlled study. Journal of Research in Medical Sciences2015;20:595‐601. ">Daghaghzadeh 2015</a>; <a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>), while the other studies examined just one IBD subtype. The overall evidence base is not complete. All of the included studies had small sample sizes and we were unable to collect data for some of our pre‐specified outcomes (e.g. pain severity and surgery). Several outcomes were only reported by one study (e.g. CRP, cytokines, faecal calprotectin, endoscopic relapse, hospital admissions, need for steroids). The four studies assessed different classes of antidepressants, thus the evidence supporting the use of any particular type of antidepressant is sparse. The certainty of this evidence was very low and further studies are needed before firm conclusions can be drawn. </p> </section> <section id="CD012680-sec-0085"> <h3 class="title" id="CD012680-sec-0085">Quality of the evidence</h3> <p>One RCT was rated as low risk of bias (<a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). The other RCT was rated as high risk of bias for incomplete outcome data. The non‐randomised controlled trial was rated as high risk of bias for random sequence generation, allocation concealment, and blinding of participants and personnel. Although the observational study scored well on the Newcastle‐Ottawa scale, it is still considered to be at high risk of bias in comparison to RCTs given its observational design (<a href="./references#CD012680-bbs2-0003" title="GoodhandJR , GreigFIS , KoodunY , McDermottA , WahedM , LangmeadL , et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study. Inflammatory Bowel Diseases2012;18(7):1232‐9. ">Goodhand 2012</a>). </p> <p>The GRADE analysis indicated that the overall certainty of the evidence supporting the outcomes of anxiety, depression, QoL, adverse events, and disease activity was low or very low due to very serious imprecision and high risk of bias (incomplete outcome data) in one study. </p> </section> <section id="CD012680-sec-0086"> <h3 class="title" id="CD012680-sec-0086">Potential biases in the review process</h3> <p>Measures were taken to ensure the reviewers who co‐authored one of the included trials would not extract data or assess study quality (<a href="./references#CD012680-bbs2-0004" title="Mikocka‐WalusA , HughesPA , BamptonP , GordonA , CampanielloMA , MavrangelosC , et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo‐controlled trial. Journal of Crohn's and Colitis2016;11(4):509‐14. ">Mikocka‐Walus 2016c</a>). Authors not involved in the previous trial (SLP, SK, JP) undertook this task. All studies were assessed for inclusion by two independent authors and any disagreements were resolved by a third author. All data were extracted independently by two authors. Further, to reduce any language bias, language restrictions were not imposed on the current review and the included Polish study was translated (<a href="./references#CD012680-bbs2-0001" title="ChojnackiC , Walecka‐KapicaE , KlupinskaG , PawlowiczM , FlorkowskiA , Wachowska‐KellyP , et al. Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission. Polski Merkuriusz Lekarski2011;31(182):92‐6. ">Chojnacki 2011</a>), as well as the two non‐English excluded studies (<a href="./references#CD012680-bbs2-0006" title="EirundW . Positive attendant effects of Paroxetin in Colitis ulcerosa. Psychiatrische Praxis1998;25(1):49. ">Eirund 1998</a>; <a href="./references#CD012680-bbs2-0015" title="XieR , GaoC , WuS , YanW , MaT . Clinical observation of flupentixol and melitracen combined with mesalazine for treatment of ulcerative colitis patients with anxiety and depression. Chinese Journal of Gastroenterology2014;19(10):599‐602. ">Xie 2014</a>). </p> <p>The limitations of the present review include the deviation from an RCT design usually used in effectiveness reviews. We decided to broaden our inclusion criteria to include non‐randomised studies in order to increase the number of included studies in the review. We decided against conducting a subgroup analysis based on type of IBD (i.e. Crohn's disease or ulcerative colitis) due to the very small sample size per comparison group. We also decided to use a fixed‐effect model for our analysis even when heterogeneity was considerable. We realise this decision may be controversial, but it was dictated by the desire to reduce bias inherent in reviews including studies with small sample sizes. While we attempted a meta‐analysis, only the data for nausea at 12 months could be combined as the heterogeneity was low. All other data where two studies are presented on the forest plot could not be combined due to high levels of heterogeneity. </p> </section> <section id="CD012680-sec-0087"> <h3 class="title" id="CD012680-sec-0087">Agreements and disagreements with other studies or reviews</h3> <p>The results of this review agree with the two previous reviews which relied on data synthesis only (<a href="./references#CD012680-bbs2-0047" title="MacerB , PradyS , Mikocka‐WalusA . Antidepressants in inflammatory bowel disease: A systematic review. Inflammatory Bowel Diseases2017;23(4):534‐50. ">Macer 2017</a>; <a href="./references#CD012680-bbs2-0050" title="Mikocka‐WalusAA , TurnbullDA , MouldingNT , WilsonIG , AndrewsJM , HoltmannGJ . Antidepressants and inflammatory bowel disease: a systematic review. Clinical Practice and Epidemiology in Mental Health2006;2:24. ">Mikocka‐Walus 2006</a>). The present review is the first attempt at a meta‐analysis in the area. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012680-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012680-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/full#CD012680-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012680-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/full#CD012680-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012680-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/full#CD012680-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 1 Anxiety at 12 weeks." data-id="CD012680-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 1 Anxiety at 12 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 2 Anxiety at 12 months." data-id="CD012680-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 2 Anxiety at 12 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 3 Depression at 12 weeks." data-id="CD012680-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 3 Depression at 12 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 4 Depression at 12 months." data-id="CD012680-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 4 Depression at 12 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 5 Adverse events at 12 months." data-id="CD012680-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 5 Adverse events at 12 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 6 Adverse events: nausea at 12 weeks." data-id="CD012680-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 6 Adverse events: nausea at 12 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 7 Adverse events: nausea at 12 months." data-id="CD012680-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 7 Adverse events: nausea at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 8 Study withdrawal due to adverse events at 12 weeks." data-id="CD012680-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 8 Study withdrawal due to adverse events at 12 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 9 Study withdrawal due to adverse events at 12 months." data-id="CD012680-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 9 Study withdrawal due to adverse events at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 10 Physical QoL at 12 weeks." data-id="CD012680-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 10 Physical QoL at 12 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 11 Physical QoL at 12 months." data-id="CD012680-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 11 Physical QoL at 12 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 12 Psychological QoL at 12 weeks." data-id="CD012680-fig-0015" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 12 Psychological QoL at 12 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 13 Psychological QoL at 12 months." data-id="CD012680-fig-0016" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 13 Psychological QoL at 12 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 14 Social QoL at 12 weeks." data-id="CD012680-fig-0017" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 14 Social QoL at 12 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 15 Social QoL at 12 months." data-id="CD012680-fig-0018" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 15 Social QoL at 12 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 16 Environmental QoL at 12 weeks." data-id="CD012680-fig-0019" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 16 Environmental QoL at 12 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 17 Environmental QoL at 12 months." data-id="CD012680-fig-0020" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 17 Environmental QoL at 12 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 18 Clinical remission at 12 months." data-id="CD012680-fig-0021" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 18 Clinical remission at 12 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 19 Disease activity at 12 weeks." data-id="CD012680-fig-0022" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 19 Disease activity at 12 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 20 Disease activity at 12 months." data-id="CD012680-fig-0023" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 20 Disease activity at 12 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 21 Endoscopic relapse at 12 months." data-id="CD012680-fig-0024" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 21 Endoscopic relapse at 12 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 22 Relapse using faecal calprotectin at 12 months." data-id="CD012680-fig-0025" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 22 Relapse using faecal calprotectin at 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 23 CRP at 12 months." data-id="CD012680-fig-0026" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 23 CRP at 12 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 24 Cytokines TH Effector Memory RA at 6 months." data-id="CD012680-fig-0027" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 24 Cytokines TH Effector Memory RA at 6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 25 Cytokines TC Effector Memory RA at 6 months." data-id="CD012680-fig-0028" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 25 Cytokines TC Effector Memory RA at 6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 26 Interleukin‐10 at 6 months." data-id="CD012680-fig-0029" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 26 Interleukin‐10 at 6 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012680-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/urn:x-wiley:14651858:media:CD012680:CD012680-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_t/tCD012680-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressants versus placebo, Outcome 27 Need for steroids at 12 months." data-id="CD012680-fig-0030" src="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 Antidepressants versus placebo, Outcome 27 Need for steroids at 12 months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/media/CDSR/CD012680/image_n/nCD012680-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012680-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antidepressants compared to placebo for inflammatory bowel disease</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Antidepressants compared to placebo for inflammatory bowel disease</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> participants with active and inactive inflammatory bowel disease<br/> <b>Setting:</b> Outpatient<br/> <b>Intervention:</b> Antidepressants<br/> <b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Antidepressants</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anxiety at 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean anxiety was 8.5 (SD = 3.45)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean anxiety was 6.11 (SD = 3)</p> <p>MD 2.39 lower<br/> (‐4.3 lower to ‐0.48 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anxiety was assessed using the HADS</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anxiety at 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean anxiety was 4.2 (SD = 4.9)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean anxiety was 3.8 (SD = 2.5)</p> <p>MD ‐0.40 lower<br/> (‐3.47 lower to 2.67 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anxiety was assessed using the HADS</p> <p>A second non‐randomised study using the HARS reported a mean score of 12.65 + 3.76 in the antidepressant group (n = 30) compared to 17.85 + 3.33 in the placebo group (n = 30) (MD ‐5.20, 95% CI ‐7 to ‐3.40; very low certainty evidence) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depression at 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean depression was 10.5 (SD = 3.57)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean depression was 7.47 (SD = 2.42)</p> <p>MD ‐3.03 lower<br/> (‐4.83 lower to ‐1.23 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depression was assessed using the HADS</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depression at 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean depression was 3.1 (SD = 3.4)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean depression was 2.9 (SD = 2.8)</p> <p>MD ‐0.20 lower<br/> (‐2.62 lower to 2.22 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depression was assessed using the HADS</p> <p>A second non‐randomised study using the Beck Depression Inventory reported a mean score of 9.6 + 2.76 in the antidepressant group (n = 30) compared to 16.35 + 5.41 in the placebo group (n = 30) (MD ‐6.75, 95% CI ‐8.92 to ‐4.58; very low certainty evidence) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events at 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>250 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>573 per 1,000<br/> (195 to 1,000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.29<br/> (0.78 to 6.73) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Commonly reported adverse events include nausea, headache, dizziness, drowsiness, sexual problems, insomnia, fatigue, low mood/anxiety, dry mouth muscle spasms and hot flushes </p> <p>None of the included studies reported any serious adverse events</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1, 2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life was assessed using the WHO‐QOL‐BREF</p> <p>We were unable to pool data as the outcome was reported at 12 weeks in 1 trial (44 participants) and 12 months in 1 trial (26 participants). Physical, Psychological, Social and Environmental QoL were improved only at 12 weeks with no group difference at 12 months </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maintenance of remission at 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>667 per 1,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>640 per 1,000<br/> (367 to 1,000) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.96<br/> (0.55 to 1.69) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26<br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maintenance of remission was measured by the CDAI (&lt; 150) and fecal calprotectin levels</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endoscopic relapse at 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 1,000<br/> (0 to 0) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.14<br/> (0.01 to 2.65) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60<br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐randomised study. We were unable to calculate absolute effects. Endoscopic relapse occurred in 0% (0/30) of participants in the antidepressants group compared to 10% (3/30) in the placebo group </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>CMD</b> : Common mental disorders; <b>MD</b> : Mean Difference; <b>HADS:</b> Hospital Anxiety and Depression Scale; <b>HARS:</b> Hamilton Anxiety Rating Scale; <b>RR:</b> Risk Ratio; <b>WHO‐QOL‐BREF</b>: World Health Organization Quality of Life abbreviated questionnaire </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to serious imprecision (44 participants) </p> <p><sup>2</sup> Downgraded one level due to high risk of bias (incomplete outcome data) </p> <p><sup>3</sup> Downgraded two levels due very serious imprecision (26 participants) </p> <p><sup>4</sup> Downgraded two levels due very serious imprecision (11 events) </p> <p><sup>5</sup> Downgraded two levels due very serious imprecision (17 events). </p> <p><sup>6</sup> Downgraded one level due to very serious imprecision (3 events) and a large CI around the point estimate </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antidepressants compared to placebo for inflammatory bowel disease</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/full#CD012680-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012680-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Newcastle‐Ottawa Scale results for observational study by Goodhand 2012</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case Control Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Is the case definition adequate? (/1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Representativeness of the cases (/1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Selection of controls (/1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Definition of controls (/1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comparability of cases and controls on the basis of the design or analysis (/2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assessment of exposure (/1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Same method of ascertainment for cases and controls (/1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Non‐Response Rate (/1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Goodhand (2012)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Newcastle‐Ottawa Scale results for observational study by Goodhand 2012</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/full#CD012680-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012680-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antidepressants versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Anxiety at 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Anxiety at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Depression at 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Depression at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Adverse events at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Adverse events: nausea at 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Adverse events: nausea at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.02 [0.74, 22.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Study withdrawal due to adverse events at 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Study withdrawal due to adverse events at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Physical QoL at 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Physical QoL at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Psychological QoL at 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Psychological QoL at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Social QoL at 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Social QoL at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Environmental QoL at 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Environmental QoL at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Clinical remission at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Disease activity at 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Disease activity at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Endoscopic relapse at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Relapse using faecal calprotectin at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 CRP at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Cytokines TH Effector Memory RA at 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Cytokines TC Effector Memory RA at 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Interleukin‐10 at 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Need for steroids at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antidepressants versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012680.pub2/references#CD012680-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012680.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD012680-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012680-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD012680-note-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD012680-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD012680-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012680\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012680\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012680\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012680\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012680\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012680\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012680\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012680\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012680\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012680\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012680\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012680\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012680\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012680\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012680\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012680\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012680\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012680\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=gpg7sF9V&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012680.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012680.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012680.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012680.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012680.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719493827"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012680.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719493831"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012680.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dea0def599373',t:'MTc0MDcxOTQ5NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 